Hans Vasen
Emeritus hoogleraar Preventie bij erfelijke tumoren
- Naam
- Prof. dr. H.F.A. Vasen
- h.f.a.vasen@lumc.nl
- ORCID iD
- null
De profieltekst van Prof.dr. Hans Vasen is momenteel alleen op de Engelstalige pagina beschikbaar.
Emeritus hoogleraar Preventie bij erfelijke tumoren
- LUMC
- Langers, A.M.J.; Boonstra, J.J.; Hardwick, J.C.H.; Kraan, J. van der; Sarasqueta, A.F. & Vasen, H.F.A. (2019), Endoscopic full thickness resection for early colon cancer in Lynch syndrome, Familial Cancer 18(3): 349-352.
- Elsayed, F.A.; Tops, C.M.J.; Nielsen, M.; Ruano, I.; Vasen, H.F.A.; Morreau, H.; Hes, F.J. & Wezel, T. van (2019), Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps, Molecular Genetics and Genomic Medicine 7(4).
- Schubert, S.A.; Ruano, D.; Elsayed, F.A.; Boot, A.; Crobach, S.; Sarasqueta, A.F.; Wolffenbuttel, B.; Klauw, M.M. van der; Oosting, J.; Tops, C.M.; Eijk, R. van; Vasen, H.F.A.; Vossen, R.H.A.M.; Nielsen, M.; Castellvi-Bel, S.; Ruiz-Ponte, C.; Tomlinson, I.; Dunlop, M.G.; Vodicka, P.; Wijnen, J.T.; Hes, F.J.; Morreau, H.; Miranda, N.F.C.C. de; Sijmons, R.H. & Wezel, T. van (2017), Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia, British Journal of Cancer 117(8): 1215-1223.
- Elsayed, F.A.; Kets, C.M.; Ruano, D.; Akker, B. van den; Mensenkamp, A.R.; Schrumpf, M.; Nielsen, M.; Wijnen, J.T.; Tops, C.M.; Ligtenberg, M.J.; Vasen, H.F.A.; Hes, F.J.; Morreau, H. & Wezel, T. van (2015), Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer, European Journal of Human Genetics 23(8): 1080-1084.
- Goshayeshi, L.; Hoorang, S.; Hoseini, B.; Abbaszadegan, M.R.; Afrazeh, M.; Alimardani, M.; Maghool, F.; Shademan, M.; Zahedi, M.; Zeinalian, M.; Alborzi, F.; Keramati, M.R.; Torshizian, A.; Vosoghinia, H.; Rajabzadeh, F.; Bary, A.; Bahar, M.; Javadmanesh, A.; Sorouri-Khorashad, J.; Emami, M.H.; Daryani, N.E.; Vasen, H.F.A.; Goshayeshi, L. & Dehghani, H. (2025), Germline variants in patients from the Iranian hereditary colorectal cancer registry, Cancer Cell International 25(1).
- Wifferen, F. van; Greuter, M.J.E.; Leerdam, M.E.V.; Spanier, M.B.W.; Dekker, E.; Vasen, H.F.A.; Lansdorp-Vogelaar, I.; Canfell, K.; Meijer, G.A.; Bisseling, T.M.; Hoogerbrugge, N. & Coupé, V.M.H. (2025), Combining colonoscopy with fecal immunochemical test can improve current familial colorectal cancer colonoscopy surveillance, Gastroenterology 168(1): 136-149.
- Hodgson, S.V. & Vasen, H.F.A. (2025), Advancing care for Lynch syndrome patients in China: challenges and opportunities, Familial Cancer 24(2).
- Vasen, H.F.A. (2025), Significant progress in hereditary gastrointestinal cancer research presented at the meeting of the International Society for Gastrointestinal Hereditary Tumors (InSiGHT) 10th meeting of InSiGHT, June 19th-22nd, 2024, Barcelona, Spain, Familial Cancer 25(1).
- Verhoeven, D.A.; Dekkers, N.; Boonstra, J.; Moons, L.; Hompes, R.; Bastiaansen, B.; Tuynman, J.; Koch, A.D.; Weusten, B.; Alkhalaf, A.; Belt, E.; Bemelman, W.; Consten, E.; Crobach, A.; Dang, H.; Didden, P.; Grotenhuis, B.; Hekmat, H.; Hoekstra, E.; Hout, W. van den; Huibregtse, I.; Keller, J.; Kraan, J. van der; Langers, A.; Leerdam, M. van; Marinelli, A.; Neijenhuis, P.; Omloo, J.; Pronk, A.; Roomer, R.; Rodriguez-Girondo, M.; Schrauwen, R.; Schwartz, M.; Verseveld, M.; Cappel, W.D.T.N.; Wely, B. van; Westerterp, M.; Westreenen, E. van; Lai, J.A.T.; Hove, R. ten; Vasen, H.; Doornebosch, P. & Hardwick, J. (2025), MULTICENTER, RANDOMIZED NON-INFERIORITY TRIAL COMPARING TRANSANAL MINIMAL INVASIVE SURGERY (TAMIS) AND ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR RESECTION OF NON-PEDUNCULATED RECTAL LESIONS, Gastrointestinal Endoscopy 101(5).
- Wifferen, F. van; Greuter, M.J.E.; Leerdam, M.E.V.; Spanier, M.B.W.; Dekker, E.; Vasen, H.F.A.; Lansdorp-Vogelaar, I.; Canfell, K.; Meijer, G.A.; Bisseling, T.M.; Hoogerbrugge, N. & Coupé, V.M.H. (2025), Combining colonoscopy with fecal immunochemical test can improve current familial colorectal cancer colonoscopy surveillance, Gastroenterology 168(1): 136-149.
- Bogdanski, A.M.; Onnekink, A.M.; Inderson, A.; Boekestijn, B.; Bonsing, B.A.; Vasen, H.F.A.; Hooft, J.E. van; Boonstra, J.J.; Mieog, J.S.D.; Wasser, M.N.J.M.; Feshtali, S.; Potjer, T.P.; Klatte, D.C.F. & Leerdam, M.E. van (2024), The added value of blood glucose monitoring in high-risk individuals undergoing pancreatic cancer surveillance, Pancreas 53(7): e566-e572.
- Boekestijn, B.; Feshtali, S.; Vasen, H.; Leerdam, M.E. van; Bonsing, B.A.; Mieog, J.S.D. & Wasser, M.N. (2024), Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions, Familial Cancer 23(3): 295-308.
- Klatte, D.C.F.; Boekestijn, B.; Onnekink, A.M.; Dekker, F.W.; Geest, L.G. van der; Wasser, M.N.J.M.; Feshtali, S.; Luelmo, S.A.C.; Morreau, H.; Potjer, T.P.; Inderson, A.; Boonstra, J.J.; Vasen, H.F.A.; Hooft, J.E. van; Bonsing, B.A.; Leerdam, M.E. van & Dutch Pancreatic Canc Grp (2023), Surveillance for pancreatic cancer in high-risk individuals leads to improved outcomes, Gastroenterology 164(7).
- Klatte, D.C.F.; Boekestijn, B.; Onnekink, A.M.; Dekker, F.W.; Geest, L.G. van der; Wasser, M.N.J.M.M.; Feshtali, S.; Mieog, J.S.D.; Morreau, H.; Potjer, T.P.; Inderson, A.; Boonstra, J.J.; Vasen, H.F.A.; Luelmo, S.; Hooft, J.E. van; Bonsing, B.A. & Leerdam, M.E. van (2023), Comparison of pancreatic cancer outcomes diagnosed in surveillance and the general population: A propensity score-matched analysis., Journal of Clinical Oncology 41: 690-690.
- Klatte, D.C.; Boekestijn, B.; Onnekink, A.; Dekker, F.; Geest, L. van der; Wasser, M.; Feshtali, S.S.; Mieog, J.S.; Luelmo, S.; Morreau, H.; Potjer, T.; Inderson, A.; Boonstra, J.; Vasen, H.; Hooft, J.E. van; Bonsing, B.A. & Leerdam, M. van (2023), SURVEILLANCE FOR PANCREATIC CANCER IN HIGH-RISK INDIVIDUALS LEADS TO IMPROVED OUTCOMES: A PROPENSITY SCORE-MATCHED ANALYSIS, Gastroenterology 164(6): S770-S770.
- Bogdanski, A.; Klatte, D.C.; Onnekink, A.; Boekestijn, B.; Wasser, M.; Feshtali, S.S.; Bonsing, B.A.; Mieog, J.S.; Hooft, J.E. van & Leerdam, M. van (2023), THE ADDED VALUE OF BLOOD GLUCOSE MONITORING IN HIGH-RISK INDIVIDUALS UNDERGOING PANCREATIC CANCER SURVEILLANCE., Gastroenterology 164(6): S598-S598.
- Ibrahim, I.S.; Vasen, H.F.A.; Wasser, M.N.J.M.; Feshtali, S.; Bonsing, B.A.; Morreau, H.; Inderson, A.; Cappel, W.H.D.T.N. & Hout, W.B. van den (2023), Cost-effectiveness of pancreas surveillance, United European Gastroenterology Journal 11(2).
- Vasen, H.F.A. (2022), Progress Report: New insights into the prevention of CRC by colonoscopic surveillance in Lynch syndrome, Familial Cancer 21(1): 49-56.
- Klatte, D.C.F.; Boekestijn, B.; Wasser, M.N.J.M.; Shahbazi, S.F.; Ibrahim, I.S.; Mieog, J.S.D.; Luelmo, S.A.C.; Morreau, H.; Potjer, T.P.; Inderson, A.; Boonstra, J.J.; Dekker, F.W.; Vasen, H.F.A.; Hooft, J.E. van; Bonsing, B.A. & Leerdam, M.E. van (2022), Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up, Journal of Clinical Oncology 40(28): 3267-+.
- Leicher, L.W.; Huisman, J.F.; Grevenstein, W.M.U. van; Didden, P.; Backes, Y.; Offerhaus, G.J.A.; Lacle, M.M.; Moll, F.C.P.; Geesing, J.M.J.; Smakman, N.; Droste, J.S.T.S.; Verdaasdonk, E.G.G.; Borg, F. ter; Talsma, A.K.; Erkelens, G.W.; Zaag, E.S. van der; Schrauwen, R.W.M.; Wely, B.J. van; Schot, I.; Vermaas, M.; Bergeijk, J.D. van; Sietses, C.; Hazen, W.L.; Wasowicz, D.K.; Ramsoekh, D.; Tuynman, J.B.; Alderlieste, Y.A.; Renger, R.J.; Oort, F.A.; Bilgen, E.J.S.; Vleggaar, F.P.; Vasen, H.F.A.; Cappel, W.H.D.T.N.; Moons, L.M.G. & Westreenen, H.L. van (2022), Colonoscopic-assisted laparoscopic wedge resection for colonic lesions A Prospective Multicenter Cohort Study (LIMERIC-Study), Annals of Surgery 275(5): 933-939.
- Levink, I.J.M.; Klatte, D.C.F.; Hanna-Sawires, R.G.; Vreeker, G.C.M.; Ibrahim, I.S.; Burgt, Y.E.M. van der; Overbeek, K.A.; Koopmann, B.D.M.; Cahen, D.L.; Fuhler, G.M.; Wuhrer, M.; Bonsing, B.A.; Tollenaar, R.A.E.M.; Vleggaar, F.P.; Vasen, H.F.A.; Leerdam, M.E. van; Bruno, M.J. & Mesker, W.E. (2022), Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals, Pancreatology 22(4): 497-506.
- Ghorbanoghli, Z.; Kouwen, M. van; Versluys, B.; Bonnet, D.; Devalck, C.; Tinat, J.; Januszkiewicz-Lewandowska, D.; Costas, C.C.; Cottereau, E.; Hardwick, J.C.H.; Wimmer, K.; Brugieres, L.; Colas, C. & Vasen, H.F.A. (2022), High yield of surveillance in patients diagnosed with constitutional mismatch repair deficiency, Journal of Medical Genetics.
- Klatte, D.; Boekestijn, B.; Wasser, M.; Feshtali, S.S.; Ibrahim, I.; Mieog, J.S.; Luelmo, S.; Morreau, H.; Potjer, T.; Inderson, A.; Boonstra, J.; Dekker, F.; Vasen, H.F.; Hooft, J.E. van; Bonsing, B.A. & Leerdam, M. van (2022), PANCREATIC CANCER SURVEILLANCE IN CDKN2A MUTATION CARRIERS: YIELD AND OUTCOMES OF 20 YEARS PROSPECTIVE FOLLOW-UP, Gastroenterology 162(7): S51-S51.
- Brouwer, J.G.M.; Newcomb, P.A.; Bisseling, T.M.; Figueiredo, J.C.; Hopper, J.L.; Jenkins, M.A.; Koornstra, J.J.; Lindor, N.M.; Vasen, H.F.A.; Win, A.K.; Kampman, E. & Duijnhoven, F.J.B. van (2021), Associations of height with the risks of colorectal and endometrial cancer in persons with Lynch syndrome, American Journal of Epidemiology 190(2): 230-238.
- Wiik, M.U.; Evans, T.J.; Belhadj, S.; Bolton, K.A.; Dymerska, D.; Jagmohan-Changur, S.; Capella, G.; Kurzawski, G.; Wijnen, J.T.; Valle, L.; Vasen, H.F.A.; Lubinski, J.; Scott, R.J. & Talseth-Palmer, B.A. (2021), A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants, Scientific Reports 11(1).
- Dominguez-Valentin, M.; Plazzer, J.P.; Sampson, J.R.; Engel, C.; Aretz, S.; Jenkins, M.A.; Sunde, L.; Bernstein, I.; Capella, G.; Balaguer, F.; Macrae, F.; Winship, I.M.; Thomas, H.; Evans, D.G.; Burn, J.; Greenblatt, M.; Cappel, W.H.D.T.N.; Sijmons, R.H.; Nielsen, M.; Bertario, L.; Bonanni, B.; Tibiletti, M.G.; Cavestro, G.M.; Lindblom, A.; Valle, A. della; Lopez-Kostner, F.; Alvarez, K.; Gluck, N.; Katz, L.; Heinimann, K.; Vaccaro, C.A.; Nakken, S.; Hovig, E.; Green, K.; Lalloo, F.; Hill, J.; Vasen, H.F.A.; Perne, C.; Buttner, R.; Gorgens, H.; Holinski-Feder, E.; Morak, M.; Holzapfel, S.; Huneburg, R.; Doeberitz, M.V.; Loeffler, M.; Rahner, N.; Weitz, J.; Steinke-Lange, V.; Schmiegel, W.; Vangala, D.; Crosbie, E.J.; Pineda, M.; Navarro, M.; Brunet, J.; Moreira, L.; Sanchez, A.; Serra-Burriel, M.; Mints, M.; Kariv, R.; Rosner, G.; Pinero, T.A.; Pavicic, W.H.; Kalfayan, P.; Broeke, S.W. ten; Mecklin, J.P.; Pylvanainen, K.; Renkonen-Sinisalo, L.; Lepisto, A.; Peltomaki, P.; Hopper, J.L.; Win, A.K.; Buchanan, D.D.; Lindor, N.M.; Gallinger, S.; Marchand, L. le; Newcomb, P.A.; Figueiredo, J.C.; Thibodeau, S.N.; Therkildsen, C.; Hansen, T.V.O.; Lindberg, L.; Rodland, E.A.; Neffa, F.; Esperon, P.; Tjandra, D.; Moslein, G.; Seppala, T.T. & Moller, P. (2021), No difference in penetrance between truncating and missense/aberrant splicing pathogenic variants in MLH1 and MSH2, Journal of Clinical Medicine 10(13).
- Vasen, H.F.A. (2021), Progress Report, Familial Cancer 21.
- Hanna-Sawires, R.G.; Schiphuis, J.H.; Wuhrer, M.; Vasen, H.F.A.; Leerdam, M.E. van; Bonsing, B.A.; Mesker, W.E.; Burgt, Y.E.M. van der & Tollenaar, R.A.E.M. (2021), Clinical perspective on proteomic and glycomic biomarkers for diagnosis, prognosis, and prediction of pancreatic cancer, International Journal of Molecular Sciences 22(5).
- Overbeek, K.A.; Rodriguez-Girondo, M.D.M.; Wagner, A.; Stoep, N. van der; Akker, P.C. van den; Oosterwijk, J.C.; Os, T.A. van; Kolk, L.E. van der; Vasen, H.F.A.; Hes, F.J.; Cahen, D.L.; Bruno, M.J. & Potjer, T.P. (2021), Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants, Journal of Medical Genetics 58(4): 264-269.
- Ahadova, A.; Seppala, T.T.; Engel, C.; Gallon, R.; Burn, J.; Holinski-Feder, E.; Steinke-Lange, V.; Moslein, G.; Nielsen, M.; Broeke, S.W. ten; Laghi, L.; Dominguez-Valentin, M.; Capella, G.; Macrae, F.; Scott, R.; Huneburg, R.; Nattermann, J.; Hoffmeister, M.; Brenner, H.; Blaker, H.; Doeberitz, M.V.; Sampson, J.R.; Vasen, H.; Mecklin, J.P.; Moller, P. & Kloor, M. (2021), The "unnatural" history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance, International Journal of Cancer 148(4): 800-811.
- Seppala, T.T.; Dominguez-Valentin, M.; Crosbie, E.J.; Engel, C.; Aretz, S.; Macrae, F.; Winship, I.; Capella, G.; Thomas, H.; Hovig, E.; Nielsen, M.; Sijmons, R.H.; Bertario, L.; Bonanni, B.; Tibiletti, M.G.; Cavestro, G.M.; Mints, M.; Gluck, N.; Katz, L.; Heinimann, K.; Vaccaro, C.A.; Green, K.; Lalloo, F.; Hill, J.; Schmiegel, W.; Vangala, D.; Perne, C.; Strauss, H.G.; Tecklenburg, J.; Holinski-Feder, E.; Steinke-Lange, V.; Mecklin, J.P.; Plazzer, J.P.; Pineda, M.; Navarro, M.; Vida, J.B.; Kariv, R.; Rosner, G.; Pinero, T.A.; Pavicic, W.; Kalfayan, P.; Broeke, S.W. ten; Jenkins, M.A.; Sunde, L.; Bernstein, I.; Burn, J.; Greenblatt, M.; Cappel, W.H.D.T.N.; Valle, A. della; Lopez-Koestner, F.; Alvarez, K.; Buttner, R.; Gorgens, H.; Morak, M.; Holzapfel, S.; Huneburg, R.; Doeberitz, M.V.; Loeffler, M.; Redler, S.; Weitz, J.; Pylvanainen, K.; Renkonen-Sinisalo, L.; Lepisto, A.; Hopper, J.L.; Win, A.K.; Lindor, N.M.; Gallinger, S.; Marchand, L.L.; Newcomb, P.A.; Figueiredo, J.C.; Thibodeau, S.N.; Therkildsen, C.; Wadt, K.A.W.; Mourits, M.J.E.; Ketabi, Z.; Denton, O.G.; Rodland, E.A.; Vasen, H.; Neffa, F.; Esperon, P.; Tjandra, D.; Moslein, G.; Rokkones, E.; Sampson, J.R.; Evans, D.G. & Moller, P. (2021), Uptake of hysterectomy and bilateral salpingooophorectomy in carriers of pathogenic mismatch repair variants, European Journal of Cancer 148: 124-133.
- Thomas, L.E.; Hurley, J.J.; Sanchez, A.A.; Aznarez, M.R.; Backman, A.S.; Bjork, J.; Capella, G.; Clark, S.K.; Colas, C.; Dekker, E.; Dolwani, S.; Ghorbanoghli, Z.; Gonn, M.; Romero, S.G.; Hes, F.J.; Jundi, H.; Kelland, S.; Latchford, A.R.; Brito, H.L.; Lynch, P.M.; Meuser, E.; Mork, M.E.; Mort, M.; Garcia, M.N.; Nielsen, M.; Parc, Y.; Ricci, M.T.; Saurin, J.C.; Tuin, K. van der; Vasen, H.; Vilar, E.; Vinet, O.; Vitellaro, M.; Walton, S.J.; West, H.D.; Sampson, J.R. & Collaborative Grp Duodenal (2021), Duodenal adenomas and cancer in MUTYH-associated polyposis: an international cohort study, Gastroenterology 160(3): 952-+.
- Daans, C.G.; Ghorbanoghli, Z.; Velthuizen, M.E.; Vasen, H.F.A.; Offerhaus, G.J.A.; Lacle, M.M.; Siersema, P.D.; Ausems, M.G.E.M. & Boonstra, J.J. (2020), Increased prevalence of Barrett's esophagus in patients with MUTYH-associated polyposis (MAP), Familial Cancer 19(2): 183-187.
- Dominguez-Valentin, M.; Sampson, J.R.; Seppala, T.T.; Broeke, S.W. ten; Plazzer, J.P.; Nakken, S.; Engel, C.; Aretz, S.; Jenkins, M.A.; Sunde, L.; Bernstein, I.; Capella, G.; Balaguer, F.; Thomas, H.; Evans, D.G.; Burn, J.; Greenblatt, M.; Hovig, E.; Cappel, W.H.D.T.N.C.; Sijmons, R.H.; Bertario, L.; Tibiletti, M.G.; Cavestro, G.M.; Lindblom, A.; Valle, A. della; Lopez-Kostner, F.; Gluck, N.; Katz, L.H.; Heinimann, K.; Vaccaro, C.A.; Buttner, R.; Gorgens, H.; Holinski-Feder, E.; Morak, M.; Holzapfel, S.; Huneburg, R.; Doeberitz, M.V.; Loeffler, M.; Rahner, N.; Schackert, H.K.; Steinke-Lange, V.; Schmiegel, W.; Vangala, D.; Pylvanainen, K.; Renkonen-Sinisalo, L.; Hopper, J.L.; Win, A.K.; Haile, R.W.; Lindor, N.M.; Gallinger, S.; Marchand, L. le; Newcomb, P.A.; Figueiredo, J.C.; Thibodeau, S.N.; Wadt, K.; Therkildsen, C.; Okkels, H.; Ketabi, Z.; Moreira, L.; Sanchez, A.; Serra-Burriel, M.; Pineda, M.; Navarro, M.; Blanco, I.; Green, K.; Lalloo, F.; Crosbie, E.J.; Hill, J.; Denton, O.G.; Frayling, I.M.; Rodland, E.A.; Vasen, H.; Mints, M.; Neffa, F.; Esperon, P.; Alvarez, K.; Kariv, R.; Rosner, G.; Pinero, T.A.; Gonzalez, M.L.; Kalfayan, P.; Tjandra, D.; Winship, I.M.; Macrae, F.; Moslein, G.; Mecklin, J.P.; Nielsen, M. & Moller, P. (2020), Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants, Genetics in Medicine 22(1): 15-25.
- Terlouw, D.; Suerink, M.; Singh, S.S.; Gille, H.J.J.P.; Hes, F.J.; Langers, A.M.J.; Morreau, H.; Vasen, H.F.A.; Vos, Y.J.; Wezel, T. van; Tops, C.M.; Broeke, S.W. ten & Nielsen, M. (2020), Declining detection rates for APC and biallelic MUTYH variants in polyposis patients, implications for DNA testing policy, European Journal of Human Genetics 28(2): 222-230.
- Goggins, M.; Overbeek, K.A.; Brand, R.; Syngal, S.; Chiaro, M. del; Bartsch, D.K.; Bassi, C.; Carrato, A.; Farrell, J.; Fishman, E.K.; Fockens, P.; Gress, T.M.; Hooft, J.E. van; Hruban, R.H.; Kastrinos, F.; Klein, A.; Lennon, A.M.; Lucas, A.; Park, W.; Rustgi, A.; Simeone, D.; Stoffel, E.; Vasen, H.F.A.; Cahen, D.L.; Canto, M.I.; Bruno, M.; Arcidiacono, P.G.; Ashida, R.; Ausems, M.; Besselink, M.; Biermann, K.; Bonsing, B.; Brentnall, T.; Chak, A.; Early, D.; Fernandez-Del Castillo, C.; Frucht, H.; Furukawa, T.; Gallinger, S.; Geurts, J.; Koerkamp, B.G.; Hammel, P.; Hes, F.; Iglesias-Garcia, J.; Kamel, I.; Kitano, M.; Kloppel, G.; Krak, N.; Kurtz, R.; Kwon, R.; Lachter, J.; Lee, J.; Levy, M.; Malleo, G.; Meguid, C.; Maitra, A.; Margolis, D.; Offerhaus, J.; Olson, S.; Paiella, S.; Park, W.; Petersen, G.; Poley, J.W.; Real, F.X.; Saltzman, J.; Schulick, R.; Stoita, A.; Takaori, K.; Tanaka, M.; Tamm, E.; Topazian, M.; Vazquez-Sequeiros, E.; Vleggaar, F.; Cappel, W.D.T.N.; Yeo, C.; Wasser, M.; Wagner, A.; Wallace, M.; Wolfgang, C.; Wood, L. & Int Canc Pancreas Screening (2020), Management of patients with increased risk for familial pancreatic cancer, Gut 69(1): 7-17.
- Sina, M.; Ghorbanoghli, Z.; Abedrabbo, A.; Al-Mulla, F.; Sghaier, R. ben; Buisine, M.P.; Cortas, G.; Goshayeshi, L.; Hadjisavvas, A.; Hammoudeh, W.; Hamoudi, W.; Jabari, C.; Loizidou, M.A.; Majidzadeh-A, K.; Marafie, M.J.; Muslumov, G.; Rifai, L.; Seir, R.A.; Talaat, S.M.; Tunca, B.; Ziada-Bouchaar, H.; Velthuizen, M.E.; Sharara, A.I.; Ahadova, A.; Georgiou, D.; Vasen, H.F.A. & Middle East Netw (2020), Identification and management of Lynch syndrome in the Middle East and North African countries, Familial Cancer 20.
- Daans, C.G.; Ghorbanoghli, Z.; Velthuizen, M.E.; Vasen, H.F.A.; Offerhaus, G.J.A.; Lacle, M.M.; Siersema, P.D.; Ausems, M.G.E.M. & Boonstra, J.J. (2020), Increased prevalence of Barrett's esophagus in patients with MUTYH-associated polyposis (MAP), Familial Cancer 19.
- Suerink, M.; Wimmer, K.; Brugieres, L.; Colas, C.; Gallon, R.; Ripperger, T.; Benusiglio, P.R.; Bleiker, E.M.A.; Ghorbanoghli, Z.; Goldberg, Y.; Hardwick, J.C.H.; Kloor, M.; Mentec, M. le; Muleris, M.; Pineda, M.; Ruiz-Ponte, C. & Vasen, H.F.A. (2020), Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019, Familial Cancer 20.
- Dominguez-Valentin, M.; Crosbie, E.J.; Engel, C.; Aretz, S.; Macrae, F.; Winship, I.; Capella, G.; Thomas, H.; Nakken, S.; Hovig, E.; Nielsen, M.; Sijmons, R.H.; Bertario, L.; Bonanni, B.; Tibiletti, M.G.; Cavestro, G.M.; Mints, M.; Gluck, N.; Katz, L.; Heinimann, K.; Vaccaro, C.A.; Green, K.; Lalloo, F.; Hill, J.; Schmiegel, W.; Vangala, D.; Perne, C.; Strauss, H.G.; Tecklenburg, J.; Holinski-Feder, E.; Steinke-Lange, V.; Mecklin, J.P.; Plazzer, J.P.; Pineda, M.; Navarro, M.; Vidal, J.B.; Kariv, R.; Rosner, G.; Pinero, T.A.; Gonzalez, M.L.; Kalfayan, P.; Ryan, N.; Broeke, S.W. ten; Jenkins, M.A.; Sunde, L.; Bernstein, I.; Burn, J.; Greenblatt, M.; Cappel, W.H.D.T.N.; Valle, A. della; Lopez-Koestner, F.; Alvarez, K.; Buttner, R.; Gorgens, H.; Morak, M.; Holzapfel, S.; Huneburg, R.; Doeberitz, M.V.; Loeffler, M.; Rahner, N.; Weitz, J.; Pylvanainen, K.; Renkonen-Sinisalo, L.; Lepisto, A.; Auranen, A.; Hopper, J.L.; Win, A.K.; Haile, R.W.; Lindor, N.M.; Gallinger, S.; Marchand, L. le; Newcomb, P.A.; Figueiredo, J.C.; Thibodeau, S.N.; Therkildsen, C.; Okkels, H.; Ketabi, Z.; Denton, O.G.; Rodland, E.A.; Vasen, H.; Neffa, F.; Esperon, P.; Tjandra, D.; Moslein, G.; Sampson, J.R.; Evans, D.G.; Seppala, T.T. & Moller, P. (2020), Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants, Genetics in Medicine 23(4).
- Dekkers, N.; Boonstra, J.J.; Moons, L.M.G.; Hompes, R.; Bastiaansen, B.A.; Tuynman, J.B.; Koch, A.D.; Weusten, B.L.A.M.; Pronk, A.; Neijenhuis, P.A.; Westerterp, M.; Hout, W.B. van den; Langers, A.M.J.; Kraan, J. van der; Alkhalaf, A.; Lai, J.Y.L.; Borg, F. ter; Fabry, H.; Halet, E.; Schwartz, M.P.; Nagengast, W.B.; Straathof, J.W.A.; Hove, R.W.R. ten; Oterdoom, L.H.; Hoff, C.; Belt, E.J.T.; Zimmerman, D.D.E.; Hadithi, M.; Morreau, H.; Cuba, E.M.V. de; Leijtens, J.W.A.; Vasen, H.F.A.; Leerdam, M.E. van; Graaf, E.J.R. de; Doornebosch, P.G. & Hardwick, J.C.H. (2020), Transanal minimally invasive surgery (TAMIS) versus endoscopic submucosal dissection (ESD) for resection of non-pedunculated rectal lesions (TRIASSIC study): study protocol of a European multicenter randomised controlled trial, BMC Gastroenterology 20(1).
- Engel, C.; Ahadova, A.; Seppala, T.T.; Aretz, S.; Bigirwamungu-Bargeman, M.; Blaker, H.; Bucksch, K.; Buttner, R.; Cappel, W.T.D.T.; Endris, V.; Holinski-Feder, E.; Holzapfel, S.; Huneburg, R.; Jacobs, M.A.J.M.; Koornstra, J.J.; Langers, A.M.; Lepisto, A.; Morak, M.; Moslein, G.; Peltomaki, P.; Pylvanainen, K.; Rahner, N.; Renkonen-Sinisalo, L.; Schulmann, K.; Steinke-Lange, V.; Stenzinger, A.; Strassburg, C.P.; Meeberg, P.C. van de; Kouwen, M. van; Leerdam, M. van; Vangala, D.B.; Vecht, J.; Verhulst, M.L.; Doeberitz, M.V.; Weitz, J.; Zachariae, S.; Loeffler, M.; Mecklin, J.P.; Kloor, M.; Vasen, H.F.; German HNPCC Consortium; Dutch Lynch Syndrome Collaborative & Finnish Lynch Syndrome Registry (2020), Associations of pathogenic variants in MLH1, MSH2, and MSH6 with risk of colorectal adenomas and tumors and with somatic mutations in patients with Lynch syndrome, Gastroenterology 158(5): 1326-1333.
- Vermeer, N.C.A.; Valk, M.J.M. van der; Snijders, H.S.; Vasen, H.F.A.; Hoop, A.G. van der; Guicherit, O.R.; Liefers, G.J.; Velde, C.J.H. van de; Stiggelbout, A.M. & Peeters, K.C.M.J. (2020), Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening, Psycho-Oncology 29(6).
- Goggins, M.; Overbeek, K.A.; Brand, R.; Syngal, S.; Chiaro, M. del; Bartsch, D.K.; Carrato, A.; Farrell, J.; Fishman, E.K.; Fockens, P.; Gress, T.M.; Hooft, J.E. van; Hruban, R.H.; Kastrinos, F.; Klein, A.; Lennon, A.M.; Lucas, A.; Park, W.; Rustgi, A.; Simeone, D.; Stoffel, E.; Vasen, H.F.A.; Cahen, D.L.; Canto, M.I.; Bruno, M. & Int Canc Pancreas Screening CAPS C (2020), Management of patients with increased risk for familial pancreatic cancer, Gut 69(6).
- Brouwer, J.G.M.; Snellen, M.; Bisseling, T.M.; Koornstra, J.J.; Vasen, H.F.A.; Kampman, E. & Duijnhoven, F.J.B. van (2020), Is a colorectal neoplasm diagnosis a trigger to change dietary and other lifestyle habits for persons with Lynch syndrome?, Familial Cancer 20.
- Blatter, R.; Tschupp, B.; Aretz, S.; Bernstein, I.; Colas, C.; Evans, D.G.; Genuardi, M.; Hes, F.J.; Huneburg, R.; Jarvinen, H.; Lalloo, F.; Moeslein, G.; Renkonen-Sinisalo, L.; Resta, N.; Spier, I.; Varvara, D.; Vasen, H.; Latchford, A.R. & Heinimann, K. (2020), Disease expression in juvenile polyposis syndrome, Genetics in Medicine 22(9): 1524-1532.
- Seppala, T.T.; Ahadova, A.; Dominguez-Valentin, M.; Macrae, F.; Evans, D.G.; Therkildsen, C.; Sampson, J.; Scott, R.; Burn, J.; Moslein, G.; Bernstein, I.; Holinski-Feder, E.; Pylvanainen, K.; Renkonen-Sinisalo, L.; Lepisto, A.; Lautrup, C.K.; Lindblom, A.; Plazzer, J.P.; Winship, I.; Tjandra, D.; Katz, L.H.; Aretz, S.; Huneburg, R.; Holzapfel, S.; Heinimann, K.; Valle, A. della; Neffa, F.; Gluck, N.; Cappel, W.H.D.T.N.; Vasen, H.; Morak, M.; Steinke-Lange, V.; Engel, C.; Rahner, N.; Schmiegel, W.; Vangala, D.; Thomas, H.; Green, K.; Lalloo, F.; Crosbie, E.J.; Hill, J.; Capella, G.; Pineda, M.; Navarro, M.; Blanco, I.; Broeke, S. ten; Nielsen, M.; Ljungmann, K.; Nakken, S.; Lindor, N.; Frayling, I.; Hovig, E.; Sunde, L.; Kloor, M.; Mecklin, J.P.; Kalager, M. & Moller, P. (2019), Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report, Hereditary Cancer in Clinical Practice 17.
- Ibrahim, I.S.; Bruckner, C.; Carrato, A.; Earl, J.; Inderson, A.; Cappel, W.H.D.T.; Mintziras, L.; Matthai, E.; Figiel, J.; Wasser, M.; Moreau, H.; Bonsing, B.; Slater, E.P.; Bartsch, D.K. & Vasen, H.F. (2019), Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers, United European Gastroenterology Journal 7(5): 682-688.
- Vasen, H.F.A.; Ghorbanoghli, Z.; Ruijter, B. de; Trinidad, R.A.; Langers, A.M.J.; Peeters, K.C.M.J.; Bonsing, B.A. & Hardwick, J.C.H. (2019), Optimizing the timing of colorectal surgery in patients with familial adenomatous polyposis in clinical practice, Scandinavian Journal of Gastroenterology.
- Haanstra, J.F.; Dekker, E.; Cats, A.; Nagengast, F.M.; Hardwick, J.C.; Vanhoutvin, S.A.; Cappel, W.H.D.T.N.; Vasen, H.F.; Kleibeuker, J.H. & Koornstra, J.J. (2019), Effect of chromoendoscopy in the proximal colon on colorectal neoplasia detection in Lynch syndrome: a multicenter randomized controlled trial, Gastrointestinal Endoscopy 90(4): 624-632.
- Suerink, M.; Rodriguez-Girondo, M.; Klift, H.M. van der; Colas, C.; Brugieres, L.; Lavoine, N.; Jongmans, M.; Munar, G.C.; Evans, D.G.; Farrell, M.P.; Genuardi, M.; Goldberg, Y.; Gomez-Garcia, E.; Heinimann, K.; Hoell, J.I.; Aretz, S.; Jasperson, K.W.; Kedar, I.; Modi, M.B.; Nikolaev, S.; Os, T.A.M. van; Ripperger, T.; Rueda, D.; Senter, L.; Sjursen, W.; Sunde, L.; Therkildsen, C.; Tibiletti, M.G.; Trainer, A.H.; Vos, Y.J.; Wagner, A.; Winship, I.; Wimmer, K.; Zimmermann, S.Y.; Vasen, H.F.; Asperen, C.J. van; Houwing-Duistermaat, J.J.; Broeke, S.W. ten & Nielsen, M. (2019), An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome, Genetics in Medicine 21(12): 2706-2712.
- Halk, A.B.; Potjer, T.P.; Kukutsch, N.A.; Vasen, H.F.A.; Hes, F.J. & Doorn, R. van (2019), Surveillance for familial melanoma: recommendations from a national centre of expertise, British Journal of Dermatology 181(3): 594-596.
- Vasen, H.F.A.; Boekestijn, B.; Ibrahim, I.S.; Inderson, A.; Bonsing, B.A.; Cappel, W.H.D.T.N.; Feshtali, S. & Wasser, M.N. (2019), Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program, HPB 21(10): 1371-1375.
- Vasen, H.F.A.; Bartsch, D.K. & Carrato, A. (2019), Screening of Individuals at High Risk for Pancreatic Cancer.
- Huisman, J.F.; Westreenen, H.L. van; Wouden, E.J. van der; Vasen, H.F.A.; Graaf, E.J.R. de; Doornebosch, P.G.; Tang, T.J.; Schot, I.; Brohet, R.M.; Cappel, W.H.D.T.N. & Vermaas, M. (2019), Effectiveness of endosponge therapy for the management of presacral abscesses following rectal surgery, Techniques in Coloproctology 23(6): 551-557.
- Lakeman, I.M.M.; Hilbers, F.S.; Rodriguez-Girondo, M.; Lee, A.; Vreeswijk, M.P.G.; Hollestelle, A.; Seynaeve, C.; Meijers-Heijboer, H.; Oosterwijk, J.C.; Hoogerbrugge, N.; Olah, E.; Vasen, H.F.A.; Asperen, C.J. van & Devilee, P. (2019), Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families, Journal of Medical Genetics 56(9).
- Lakeman, I.M.M.; Hilbers, F.S.; Rodriguez-Girondo, M.; Lee, A.; Vreeswijk, M.P.G.; Hollestelle, A.; Seynaeve, C.; Meijers-Heijboer, H.; Oosterwijk, J.C.; Hoogerbrugge, N.; Olah, E.; Vasen, H.F.A.; Asperen, C.J. van & Devilee, P. (2019), Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families, Journal of Medical Genetics 56(9): 581-589.
- Suerink, M.; Ripperger, T.; Messiaen, L.; Menko, F.H.; Bourdeaut, F.; Colas, C.; Jongmans, M.; Goldberg, Y.; Nielsen, M.; Muleris, M.; Kouwen, M. van; Slavc, I.; Kratz, C.; Vasen, H.F.; Brugieres, L.; Legius, E. & Wimmer, K. (2019), Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy, Journal of Medical Genetics 56(2): 53-62.
- Leicher, L.W.; Lammertink, M.H.A.; Offerman, S.R.; Morreau, H.; Jong, M.M. de; Groot, J.W.B. de; Westreenen, H.L. van; Vasen, H.F.A. & Cappel, W.H.D.T.N. (2018), Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice, Scandinavian Journal of Gastroenterology 53(5): 632-636.
- Ibrahim, I.; Mulder, B.G.S.; Bonsing, B.; Morreau, H.; Sarasqueta, A.F.; Inderson, A.; Luelmo, S.; Feshtali, S.; Potjer, T.P.; Cappel, W.D.T.N.; Wasser, M. & Vasen, H.F.A. (2018), Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers, European Journal of Human Genetics 26(8): 1227-1229.
- Argillander, T.E.; Koornstra, J.J.; Kouwen, M. van; Langers, A.M.J.; Nagengast, F.M.; Vecht, J.; Cappel, W.H.D.V.T.N.; Dekker, E.; Duijvendijk, P. van & Vasen, H.F.A. (2018), Features of incident colorectal cancer in Lynch syndrome, United European Gastroenterology Journal 6(8): 1215-1222.
- Mulder, B.G.S.; Mieog, J.S.D.; Sarasqueta, A.F.; Handgraaf, H.J.M.; Vasen, H.F.A.; Swijnenburg, R.J.; Luelmo, S.A.C.; Feshtali, S.; Inderson, A.; Vahrmeijer, A.L.; Bonsing, B.A.; Wezel, T. van & Morreau, H. (2018), Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer, Journal of Clinical Pathology 71(3): 246-252.
- Broeke, S.W. ten; Klift, H.M. van der; Tops, C.M.J.; Aretz, S.; Bernstein, I.; Buchanan, D.D.; Chapelle, A. de la; Capella, G.; Clendenning, M.; Engel, C.; Gallinger, S.; Gomez Garcia, E.; Figueiredo, J.C.; Haile, R.; Hampel, H.L.; Hopper, J.L.; Hoogerbrugge, N.; Doeberitz, M.V.; Marchand, L. le; Letteboer, T.G.W.; Jenkins, M.A.; Lindblom, A.; Lindor, N.M.; Mensenkamp, A.R.; Moller, P.; Newcomb, P.A.; Os, T.A.M. van; Pearlman, R.; Pineda, M.; Rahner, N.; Redeker, E.J.W.; Olderode-Berends, M.J.W.; Rosty, C.; Schackert, H.K.; Scott, R.; Senter, L.; Spruijt, L.; Steinke-Lange, V.; Suerink, M.; Thibodeau, S.; Vos, Y.J.; Wagner, A.; Winship, I.; Hes, F.J.; Vasen, H.F.A.; Wijnen, J.T.; Nielsen, M. & Win, A.K. (2018), Cancer Risks for PMS2-Associated Lynch Syndrome, Journal of Clinical Oncology 36(29): 2961-+.
- Engel, C.; Vasen, H.F.; Seppala, T.; Aretz, S.; Bigirwamungu-Bargeman, M.; Boer, S.Y. de; Bucksch, K.; Buttner, R.; Holinski-Feder, E.; Holzapfel, S.; Huneburg, R.; Jacobs, M.A.J.M.; Jarvinen, H.; Kloor, M.; Doeberitz, M.V.; Koornstra, J.J.; Kouwen, M. van; Langers, A.M.; Meeberg, P.C. van de; Morak, M.; Moslein, G.; Nagengast, F.M.; Pylvanainen, K.; Rahner, N.; Renkonen-Sinisalo, L.; Sanduleanu, S.; Schackert, H.K.; Schmiegel, W.; Schulmann, K.; Steinke-Lange, V.; Strassburg, C.P.; Vecht, J.; Verhulst, M.L.; Cappel, W.D.T.N.; Zachariae, S.; Mecklin, J.P.; Loeffler, M.; German HNPCC Consortium; Dutch Lynch Syndrome & Finnish Lynch Syndrome Registry (2018), No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies, Gastroenterology 155(5): 1400-+.
- Ghorbanoghli, Z.; Jabari, C.; Sweidan, W.; Hammoudeh, W.; Cortas, G.; Sharara, A.I.; Abedrabbo, A.; Hourani, I.; Mahjoubi, B.; Majidzadeh, K.; Tozun, N.; Ziada-Bouchaar, H.; Hamoudi, W.; Diab, O.; Khorshid, H.R.K.; Lynch, H. & Vasen, H. (2018), A new hereditary colorectal cancer network in the Middle East and eastern Mediterranean countries to improve care for high-risk families (vol 17, pg 209, 2018), Familial Cancer 17(2): 213-213.
- Woolderink, J.M.; Bock, G.H. de; Hullu, J.A. de; Hollema, H.; Zweemer, R.P.; Slangen, B.F.M.; Gaarenstroom, K.N.; Beurden, M. van; Doom, H.C. van; Sijmons, R.H.; Vasen, H.F.A. & Mourits, M.J.E. (2018), Characteristics of Lynch syndrome associated ovarian cancer, Gynecologic Oncology 150(2): 324-330.
- Potjer, T.P.; Helgadottir, H.; Leenheer, M.; Stoep, N. van der; Gruis, N.A.; Hoiom, V.; Olsson, H.; Doorn, R. van; Vasen, H.F.A.; Asperen, C.J. van; Dekkers, O.M.; Hes, F.J. & Dutch Working Grp Clinical Onc (2018), CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe, Journal of Medical Genetics 55(10): 661-668.
- Moller, P.; Seppala, T.T.; Bernstein, I.; Holinski-Feder, E.; Sala, P.; Evans, D.G.; Lindblom, A.; Macrae, F.; Blanco, I.; Sijmons, R.H.; Jeffries, J.; Vasen, H.F.A.; Burn, J.; Nakken, S.; Hovig, E.; Rodland, E.A.; Tharmaratnam, K.; Cappel, W.H.D.T.N.; Hill, J.; Wijnen, J.T.; Jenkins, M.A.; Green, K.; Lalloo, F.; Sunde, L.; Mints, M.; Bertario, L.; Pineda, M.; Navarro, M.; Morak, M.; Renkonen-Sinisalo, L.; Valentin, M.D.; Frayling, I.M.; Plazzer, J.P.; Pylvanainen, K.; Genuardi, M.; Mecklin, J.P.; Moeslein, G.; Sampson, J.R.; Capella, G. & Collaboration Mallorca Grp (2018), Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database, Gut 67(7): 1306-1316.
- Vasen, H.F.A. (2018), The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer, Familial Cancer 17(1): 1-3.
- Ghorbanoghli, Z.; Bastiaansen, B.A.J.; Langers, A.M.J.; Nagengast, F.M.; Poley, J.W.; Hardwick, J.C.H.; Koornstra, J.J.; Sanduleanu, S.; Cappel, W.H.D.T.N.; Witteman, B.J.M.; Morreau, H.; Dekker, E. & Vasen, H.F.A. (2018), Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis, Journal of Medical Genetics 55(1): 11-14.
- Ibrahim, I.S.; Wasser, M.N.; Wu, Y.H.; Inderson, A.; Cappel, W.H.D.T.N.; Morreau, H.; Hes, F.J.; Veenendaal, R.A.; Putter, H.; Feshtali, S.; Mil, A.M. van; Gruis, N.A.; Tollenaar, R.A.; Bergman, W.; Bonsing, B.A. & Vasen, H.F.A. (2018), High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers, Cancer Prevention Research 11(9): 551-556.
- Moller, P.; Seppala, T.; Bernstein, I.; Holinski-Feder, E.; Sala, P.; Evans, D.G.; Lindblom, A.; Macrae, F.; Blanco, I.; Blanco, I.; Jeffries, J.; Vasen, H.; Burn, J.; Nakken, S.; Hovig, E.; Rodland, E.A.; Tharmaratnam, K.; Cappel, W.H.D.T.N.; Hill, J.; Wijnen, J.; Jenkins, M.; Green, K.; Lalloo, F.; Sunde, L.; Mints, M.; Bertario, L.; Pineda, M.; Navarro, M.; Morak, M.; Renkonen-Sinisalo, L.; Frayling, I.M.; Plazzer, J.P.; Pylvanainen, K.; Genuardi, M.; Mecklin, J.P.; Moslein, G.; Sampson, J.R.; Capella, G. & Mallorca Grp (2017), Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database, Gut 66(9): 1657-1664.
- Huisman, J.F.; Leicher, L.W.; Boer, E. de; Westreenen, H.L. van; Groot, J.W. de; Holman, F.A.; Meeberg, P.C. van de; Sallevelt, P.E.J.M.; Peeters, K.C.M.J.; Wasser, M.N.J.M.; Vasen, H.F.A. & Cappel, W.H.D.T.N. (2017), Consequences of CT colonography in stenosing colorectal cancer, International Journal of Colorectal Disease 32(3): 367-373.
- Seppala, T.; Pylvanainen, K.; Evans, D.G.; Jarvinen, H.; Renkonen-Sinisalo, L.; Bernstein, I.; Holinski-Feder, E.; Sala, P.; Lindblom, A.; Macrae, F.; Blanco, I.; Sijmons, R.; Jeffries, J.; Vasen, H.; Burn, J.; Nakken, S.; Hovig, E.; Rodland, E.A.; Tharmaratnam, K.; Cappel, W.H.D.T.N.; Hill, J.; Wijnen, J.; Jenkins, M.; Genuardi, M.; Green, K.; Lalloo, F.; Sunde, L.; Mints, M.; Bertario, L.; Pineda, M.; Navarro, M.; Morak, M.; Frayling, I.M.; Plazzer, J.P.; Sampson, J.R.; Capella, G.; Moslein, G.; Mecklin, J.P.; Moller, P. & Collaboration Mallorca Grp (2017), Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report, Hereditary Cancer in Clinical Practice 15.
- Mulder, B.G.S.; Mieog, J.S.D.; Handgraaf, H.J.M.; Sarasqueta, A.F.; Vasen, H.F.A.; Potjer, T.P.; Swijnenburg, R.J.; Luelmo, S.A.C.; Feshtali, S.; Inderson, A.; Vahrmeijer, A.L.; Bonsing, B.A.; Wezel, T. van & Morreau, H. (2017), Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer, Journal of Clinical Pathology 70(2): 174-178.
- Boonstra, J.J.; Cappel, W.H.D.T.N.; Langers, A.M.J.; Sluis, H. van der; Hardwick, J.H. & Vasen, H.F.A. (2017), Colonoscopy in Lynch syndrome: the need for a new quality score, Familial Cancer 16(2): 239-241.
- Moller, P.; Seppala, T.; Bernstein, I.; Holinski-Feder, E.; Sala, P.; Evans, D.G.; Lindblom, A.; Macrae, F.; Blanco, I.; Sijmons, R.; Jeffries, J.; Vasen, H.; Burn, J.; Nakken, S.; Hovig, E.; Rodland, E.A.; Tharmaratnam, K.; Cappel, W.H.D.T.N.; Hill, J.; Wijnen, J.; Green, K.; Lalloo, F.; Sunde, L.; Mints, M.; Bertario, L.; Pineda, M.; Navarro, M.; Morak, M.; Renkonen-Sinisalo, L.; Frayling, I.M.; Plazzer, J.P.; Pylvanainen, K.; Sampson, J.R.; Capella, G.; Mecklin, J.P.; Moslein, G. & Mallorca Grp (2017), Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database, Gut 66(3): 464-472.
- Bronsgeest, K.; Huisman, J.F.; Langers, A.; Boonstra, J.J.; Schenk, B.E.; Cappel, W.H.D.T.N.; Vasen, H.F.A. & Hardwick, J.C.H. (2017), Safety of endoscopic mucosal resection (EMR) of large non-pedunculated colorectal adenomas in the elderly, International Journal of Colorectal Disease 32(12): 1711-1717.
- Ibrahim, I.S.; Bonsing, B.A.; Swijnenburg, R.J.; Welling, L.; Veenendaal, R.A.; Wasser, M.N.J.M.; Morreau, H.; Inderson, A. & Vasen, H.F.A. (2017), Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer, Familial Cancer 16(1): 111-115.
- Haanstra, J.F.; Al-Toma, A.; Dekker, E.; Vanhoutvin, S.A.L.W.; Nagengast, F.M.; Mathus-Vliegen, E.M.; Leerdam, M.E. van; Cappel, W.H.D.T.N.; Veenendaal, R.A.; Cats, A.; Sanduleanu, S.; Vasen, H.F.A.; Kleibeuker, J.H. & Koornstra, J.J. (2017), Incidence of small bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy, Endoscopy International Open 5(7): E622-E626.
- Brouwer, J.G.M.; Makama, M.; Woudenbergh, G.J. van; Vasen, H.F.A.; Nagengast, F.M.; Kleibeuker, J.H.; Kampman, E. & Duijnhoven, F.J.B. van (2017), Inflammatory potential of the diet and colorectal tumor risk in persons with Lynch syndrome, American Journal of Clinical Nutrition 106(5): 1287-1294.
- Soer, E.C.; Leicher, L.W.; Langers, A.M.J.; Meeberg, P.C. van de; Wouden, E.J. van der; Koornstra, J.J.; Bigirwamungu-Bargeman, M.; Vasen, H.F.A. & Cappel, W.H.D.T.N. (2016), Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer, International Journal of Colorectal Disease 31(3): 693-697.
- Suerink, M.; Klift, H.M. van der; Broeke, S.W. ten; Dekkers, O.M.; Bernstein, I.; Munar, G.C.; Garcia, E.G.; Hoogerbrugge, N.; Letteboer, T.G.W.; Menko, F.H.; Lindblom, A.; Mensenkamp, A.; Moller, P.; Os, T.A. van; Rahner, N.; Redeker, B.J.W.; Olderode, M.; Spruijt, L.; Vos, Y.J.; Wagner, A.; Morreau, H.; Hes, F.J.; Vasen, H.F.A.; Tops, C.M.; Wijnen, J.T. & Nielsen, M. (2016), The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers, Genetics in Medicine 18(4): 405-409.
- Wimmer, K.; Brugieres, L.; Duval, A.; Muleris, M.; Kratz, C.P. & Vasen, H.F.A. (2016), Constitutional or biallelic? Settling on a name for a recessively inherited cancer susceptibility syndrome, Journal of Medical Genetics 53(4): 226-226.
- Jansen, A.M.L.; Geilenkirchen, M.A.; Wezel, T. van; Jagmohan-Changur, S.C.; Ruano, D.; Klift, H.M. van der; Akker, B.E.W.M. van den; Laros, J.F.J.; Galen, M. van; Wagner, A.; Letteboer, T.G.W.; Gomez-Garcia, E.B.; Tops, C.M.J.; Vasen, H.F.; Devilee, P.; Hes, F.J.; Morreau, H. & Wijnen, J.T. (2016), Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients, PLoS ONE 11(6).
- Potjer, T.P.; Mertens, B.J.; Nicolardi, S.; Burgt, Y.E.M. van der; Bonsing, B.A.; Mesker, W.E.; Tollenaar, R.A.E.M. & Vasen, H.F.A. (2016), Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort, Translational Oncology 9(3): 242-247.
- Vasen, H.; Ibrahim, I.; Ponce, C.G.; Slater, E.P.; Matthai, E.; Carrato, A.; Earl, J.; Robbers, K.; Mil, A.M. van; Potjer, T.; Bonsing, B.A.; Cappel, W.H.D.T.N.; Bergman, W.; Wasser, M.; Morreau, H.; Kloppel, G.; Schicker, C.; Steinkamp, M.; Figiel, J.; Esposito, I.; Mocci, E.; Vazquez-Sequeiros, E.; Sanjuanbenito, A.; Munoz-Beltran, M.; Montans, J.; Langer, P.; Fendrich, V. & Bartsch, D.K. (2016), Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers, Journal of Clinical Oncology 34(17): 2010-+.
- Erp, S.J.H. van; Leicher, L.W.; Hennink, S.D.; Ghorbanoghli, Z.; Breg, S.A.C.; Morreau, H.; Nielsen, M.; Hardwick, J.C.H.; Roukema, J.A.; Langers, A.M.J.; Cappel, W.H.D.T.N. & Vasen, H.F.A. (2016), Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study, Scandinavian Journal of Gastroenterology 51(10): 1227-1232.
- Ghorbanoghli, Z.; Nieuwenhuis, M.H.; Houwing-Duistermaat, J.J.; Jagmohan-Changur, S.; Hes, F.J.; Tops, C.M.; Wagner, A.; Aalfs, C.M.; Verhoef, S.; Garcia, E.B.G.; Sijmons, R.H.; Menko, F.H.; Letteboer, T.G.; Hoogerbrugge, N.; Wezel, T. van; Vasen, H.F.A. & Wijnen, J.T. (2016), Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers, Familial Cancer 15(4): 563-570.
- Bartsch, D.K.; Slater, E.P.; Carrato, A.; Ibrahim, I.S.; Guillen-Ponce, C.; Vasen, H.F.A.; Matthai, E.; Earl, J.; Jendryschek, F.S.; Figiel, J.; Steinkamp, M.; Ramaswamy, A.; Vazquez-Sequeiros, E.; Munoz-Beltran, M.; Montans, J.; Mocci, E.; Bonsing, B.A.; Wasser, M.; Kloppel, G.; Langer, P.; Fendrich, V. & Gress, T.M. (2016), Refinement of screening for familial pancreatic cancer, Gut 65(8): 1314-1321.
- Vasen, H.F.A.; Velthuizen, M.E.; Kleibeuker, J.H.; Menko, F.H.; Nagengast, F.M.; Cats, A.; Meulen-de Jong, A.E. van der; Breuning, M.H.; Roukema, A.J.; Leeuwen-Cornelisse, I. van; Cappel, W.H.D.T.N. & Wijnen, J.T. (2016), Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry, Familial Cancer 15(3): 429-435.
- Potjer, T.P.; Bartsch, D.K.; Slater, E.P.; Matthai, E.; Bonsing, B.A. & Vasen, H.F.A. (2015), Limited resection of pancreatic cancer in high-risk patients can result in a second primary, Gut 64(8): 1342-U193.
- Soer, E.; Cappel, W.H.D.T.N.; Ligtenberg, M.J.L.; Moll, F.; Pierik, R.G.; Vecht, J.; Vasen, H.F.A. & Flierman, A. (2015), Massive gastric polyposis associated with a germline SMAD4 gene mutation, Familial Cancer 14(4): 569-573.
- Velstra, B.; Vonk, M.A.; Bonsing, B.A.; Mertens, B.J.; Nicolardi, S.; Huijbers, A.; Vasen, H.; Deelder, A.M.; Mesker, W.E.; Burgt, Y.E.M. van der & Tollenaar, R.A.E.M. (2015), Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques, Journal of Cancer Research and Clinical Oncology 141(3): 531-541.
- Broeke, S.W. ten; Brohet, R.M.; Tops, C.M.; Klift, H.M. van der; Velthuizen, M.E.; Bernstein, I.; Munar, G.C.; Garcia, E.G.; Hoogerbrugge, N.; Letteboer, T.G.W.; Menko, F.H.; Lindblom, A.; Mensenkamp, A.R.; Moller, P.; Os, T.A. van; Rahner, N.; Redeker, B.J.W.; Sijmons, R.H.; Spruijt, L.; Suerink, M.; Vos, Y.J.; Wagner, A.; Hes, F.J.; Vasen, H.F.; Nielsen, M. & Wijnen, J.T. (2015), Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk, Journal of Clinical Oncology 33(4): 319-U172.
- Hennink, S.D.; Meulen-de Jong, A.E. van der; Wolterbeek, R.; Crobach, A.S.L.P.; Becx, M.C.J.M.; Crobach, W.F.S.J.; Haastert, M. van; Hove, W.R. ten; Kleibeuker, J.H.; Meijssen, M.A.C.; Nagengast, F.M.; Rijk, M.C.M.; Salemans, J.M.J.I.; Stronkhorst, A.; Tuynman, H.A.R.E.; Vecht, J.; Verhulst, M.L.; Cappel, W.H.D.T.N.; Walinga, H.; Weinhardt, O.K.; Westerveld, D.; Witte, A.M.C.; Wolters, H.J.; Cats, A.; Veenendaal, R.A.; Morreau, H. & Vasen, H.F.A. (2015), Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer, Journal of Clinical Oncology 33(35): 4188-+.
- Potjer, T.P.; Kranenburg, H.E.; Bergman, W.; Cappel, W.H.D.T.N.; Monsjou, H.S. van; Barge-Schaapveld, D.Q.C.M. & Vasen, H.F.A. (2015), Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant, European Journal of Human Genetics 23(5): 711-714.
- Aretz, S.; Vasen, H.F.A. & Olschwang, S. (2015), Clinical Utility Gene Card for: Familial adenomatous polyposis (FAP) and attenuated FAP (AFAP) - update 2014, European Journal of Human Genetics 23(6).
- Movahedi, M.; Bishop, D.T.; Macrae, F.; Mecklin, J.P.; Moeslein, G.; Olschwang, S.; Eccles, D.; Evans, D.G.; Maher, E.R.; Bertario, L.; Bisgaard, M.L.; Dunlop, M.G.; Ho, J.W.; Hodgson, S.V.; Lindblom, A.; Lubinski, J.; Morrison, P.J.; Murday, V.; Ramesar, R.S.; Side, L.; Scott, R.J.; Thomas, H.J.W.; Vasen, H.F.; Burn, J. & Mathers, J.C. (2015), Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study, Journal of Clinical Oncology 33(31): 3591-+.
- Vasen, H.F.A.; Tomlinson, I. & Castells, A. (2015), Clinical management of hereditary colorectal cancer syndromes, Nature Reviews Gastroenterology and Hepatology 12(2): 88-97.
- Timofeeva, M.N.; Kinnersley ben; Farrington, S.M.; Whiffin, N.; Palles, C.; Svinti, V.; Lloyd, A.; Gorman, M.; Ooi, L.Y.; Hosking, F.; Barclay, E.; Zgaga, L.; Dobbins, S.; Martin, L.; Theodoratou, E.; Broderick, P.; Tenesa, A.; Smillie, C.; Grimes, G.; Hayward, C.; Campbell, A.; Porteous, D.; Deary, I.J.; Harris, S.E.; Northwood, E.L.; Barrett, J.H.; Smith, G.; Wolf, R.; Forman, D.; Morreau, H.; Ruano, D.; Tops, C.; Wijnen, J.; Schrumpf, M.; Boot, A.; Vasen, H.F.A.; Hes, F.J.; Wezel, T. van; Franke, A.; Lieb, W.; Schafmayer, C.; Hampe, J.; Buch, S.; Propping, P.; Hemminki, K.; Forsti, A.; Westers, H.; Hofstra, R.; Pinheiro, M.; Pinto, C.; Teixeira, M.; Ruiz-Ponte, C.; Fernandez-Rozadilla, C.; Carracedo, A.; Castells, A.; Castellvi-Bel, S.; Campbell, H.; Bishop, D.T.; Tomlinson, I.P.M.; Dunlop, M.G. & Houlston, R.S. (2015), Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer, Scientific Reports 5.
- Vasen, H.F.A. & Bartsch, D. (2015), Familial Pancreatic Cancer: To Screen or not to Screen?, EBioMedicine 2(12).
- Out, A.A.; Minderhout, I.J.H.M. van; Stoep, N. van der; Bommel, L.S.R. van; Kluijt, I.; Aalfs, C.; Voorendt, M.; Vossen, R.H.A.M.; Nielsen, M.; Vasen, H.F.A.; Morreau, H.; Devilee, P.; Tops, C.M.J. & Hes, F.J. (2015), High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutations, Familial Cancer 14(2): 247-257.
- Haanstra, J.F.; Al-Toma, A.; Dekker, E.; Vanhoutvin, S.A.L.W.; Nagengast, F.M.; Mathus-Vliegen, E.M.; Leerdam, M.E. van; Cappel, W.H.D.T.N.; Sanduleanu, S.; Veenendaal, R.A.; Cats, A.; Vasen, H.F.A.; Kleibeuker, J.H. & Koornstra, J.J. (2015), Prevalence of small-bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy, Gut 64(10): 1578-1583.
- Bodo, S.; Colas, C.; Buhard, O.; Collura, A.; Tinat, J.; Lavoine, N.; Guilloux, A.; Chalastanis, A.; Lafitte, P.; Coulet, F.; Buisine, M.P.; Ilencikova, D.; Ruiz-Ponte, C.; Kinzel, M.; Grandjouan, S.; Brems, H.I.; Lejeune, S.; Blanche, H.; Wang, Q.; Caron, O.; Cabaret, O.; Syrcek, M.L.; Vidaud, D.; Parfait, B.; Verloes, A.; Knappe, U.J.; Soubrier, F.; Mortemousque, I.; Leis, A.; Auclair-Perrossier, J.; Frebourg, T.; Flejou, J.F.; Entz-Werle, N.; Leclerc, J.; Malka, D.; Cohen-Haguenauer, O.; Goldberg, Y.; Gerdes, A.M.; Fedhila, F.; Mathieu-Dramard, M.; Lin, R.H.; Wafaa, B.; Gauthier-Villars, M.; Bourdeaut, F.; Sheridan, E.; Vasen, H.; Brugieres, L.; Wimmer, K.; Muleris, M.; Duva, A. & European Consortium Care CMMRD (2015), Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
- Wimmer, K.; Kratz, C.P.; Vasen, H.F.A.; Caron, O.; Colas, C.; Entz-Werle, N.; Gerdes, A.M.; Goldberg, Y.; Ilencikova, D.; Muleris, M.; Duval, A.; Lavoine, N.; Ruiz-Ponte, C.; Slavc, I.; Burkhardt, B.; Brugieres, L. & EU-Consortium Care CMMRD C4CMMRD (2014), Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'Care for CMMRD' (C4CMMRD), Journal of Medical Genetics 51(6): 355-365.
- Jung, A.Y.; Duijnhoven, F.J.B. van; Nagengast, F.M.; Botma, A.; Heine-Broring, R.C.; Kleibeuker, J.H.; Vasen, H.F.A.; Harryvan, J.L.; Winkels, R.M. & Kampman, E. (2014), Dietary B vitamin and methionine intake and MTHFR C677T genotype on risk of colorectal tumors in Lynch syndrome: the GEOLynch cohort study, Cancer Causes and Control 25(9): 1119-1129.
- Vasen, H.F.A.; Ghorbanoghli, Z.; Bourdeaut, F.; Cabaret, O.; Caron, O.; Duval, A.; Entz-Werle, N.; Goldberg, Y.; Ilencikova, D.; Kratz, C.P.; Lavoine, N.; Loeffen, J.; Menko, F.H.; Muleris, M.; Sebille, G.; Colas, C.; Burkhardt, B.; Brugieres, L.; Wimmer, K. & EU Consortium Care CMMR-D C4CMMR-D (2014), Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D), Journal of Medical Genetics 51(5): 283-293.
- Hes, F.J.; Ruano, D.; Nieuwenhuis, M.; Tops, C.M.; Schrumpf, M.; Nielsen, M.; Huijts, P.E.A.; Wijnen, J.T.; Wagner, A.; Garcia, E.B.G.; Sijmons, R.H.; Menko, F.H.; Letteboer, T.G.W.; Hoogerbrugge, N.; Harryvan, J.; Kampman, E.; Morreau, H.; Vasen, H.F.A. & Wezel, T. van (2014), Colorectal cancer risk variants on 11q23 and 15q13 are associated with unexplained adenomatous polyposis, Journal of Medical Genetics 51(1): 55-60.
- Mesher, D.; Dove-Edwin, I.; Sasieni, P.; Vasen, H.; Bernstein, I.; Royer-Pokora, B.; Holinski-Feder, E.; Lalloo, F.; Evans, D.G.; Forsberg, A.; Lindblom, A. & Thomas, H. (2014), A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer, International Journal of Cancer 134(4): 939-947.
- Nieuwenhuis, M.H.; Kets, C.M.; Murphy-Ryan, M.; Yntema, H.G.; Evans, D.G.; Colas, C.; Moller, P.; Hes, F.J.; Hodgson, S.V.; Olderode-Berends, M.J.W.; Aretz, S.; Heinimann, K.; Garcia, E.B.G.; Douglas, F.; Spigelman, A.; Timshel, S.; Lindor, N.M. & Vasen, H.F.A. (2014), Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome, Familial Cancer 13(1): 57-63.
- Stolwijk, J.A.M.; Langers, A.M.J.; Hardwick, J.C.; Veenendaal, R.A.; Verspaget, H.W.; Hogezand, R.A. van; Vasen, H.F. & Meulen-de Jong, A.E. van der (2013), A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort, Scientific World Journal.
- Haanstra, J.F.; Vasen, H.F.A.; Sanduleanu, S.; Wouden, E.J. van der; Koornstra, J.J.; Kleibeuker, J.H. & Cappel, W.H.D.T.N. (2013), Quality colonoscopy and risk of interval cancer in Lynch syndrome, International Journal of Colorectal Disease 28(12): 1643-1649.
- Hazewinkel, Y.; Reitsma, J.B.; Nagengast, F.M.; Vasen, H.F.; Os, T.A.M. van; Leerdam, M.E. van; Koornstra, J.J. & Dekker, E. (2013), Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives, Familial Cancer 12(4): 669-673.
- Talseth-Palmer, B.A.; Wijnen, J.T.; Andreassen, E.K.; Barker, D.; Jagmohan-Changur, S.; Tops, C.M.; Meldrum, C.; Spigelman, A.; Hes, F.J.; Wezel, T. van; Vasen, H.F.A.; Scott, R.J. & Dutch Canc Genetics Grp (2013), The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients, Hereditary Cancer in Clinical Practice 11.
- Rondagh, E.J.A.; Gulikers, S.; Gomez-Garcia, E.B.; Vanlingen, Y.; Detisch, Y.; Winkens, B.; Vasen, H.F.A.; Masclee, A.A.M. & Sanduleanu, S. (2013), Nonpolypoid colorectal neoplasms: a challenge in endoscopic surveillance of patients with Lynch syndrome, Endoscopy 45(4): 257-264.
- Duijnhoven, F.J.B. van; Botma, A.; Winkels, R.; Nagengast, F.M.; Vasen, H.F.A. & Kampman, E. (2013), Do lifestyle factors influence colorectal cancer risk in Lynch syndrome?, Familial Cancer 12(2): 285-293.
- Cappel, W.H.D.T.N.; Jarvinen, H.J.; Lynch, P.M.; Engel, C.; Mecklin, J.P. & Vasen, H.F.A. (2013), Colorectal surveillance in Lynch syndrome families, Familial Cancer 12(2): 261-265.
- Vasen, H.F.A. & Cappel, W.H.D.T.N. (2013), A hundred years of Lynch syndrome research (1913-2013) PREFACE, Familial Cancer 12(2): 141-142.
- Talseth-Palmer, B.A.; Wijnen, J.T.; Barker, D.; Vasen, H.F.A. & Scott, R.J. (2013), Is the reported modifying effect of 8q23.3 and 11q23.1 on colorectal cancer risk for MLH1 mutation carriers valid? Reply.
- Canto, M.I.; Harinck, F.; Hruban, R.H.; Offerhaus, G.J.; Poley, J.W.; Kamel, I.; Nio, Y.; Schulick, R.S.; Bassi, C.; Kluijt, I.; Levy, M.J.; Chak, A.; Fockens, P.; Goggins, M.; Bruno, M. & Int Canc Pancreas Screening (2013), International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer, Gut 62(3): 339-347.
- Velstra, B.; Bonsing, B.A.; Mertens, B.J.; Burgt, Y.E.M. van der; Huijbers, A.; Vasen, H.; Mesker, W.E.; Deelder, A.M. & Tollenaar, R.A.E.M. (2013), Detection of pancreatic cancer using serum protein profiling, HPB 15(8): 602-610.
- Heine-Broring, R.C.; Winkels, R.M.; Botma, A.; Duijnhoven, F.J.B. van; Jung, A.Y.; Kleibeuker, J.H.; Nagengast, F.M.; Vasen, H.F.A. & Kampman, E. (2013), Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study, PLoS ONE 8(6).
- Engel, C. & Vasen, H.F.A. (2013), Estimating Cancer Risks From a Retrospective Cohort of Patients With MMR Gene Mutations Reply.
- Vasen, H.F.A.; Blanco, I.; Aktan-Collan, K.; Gopie, J.P.; Alonso, A.; Aretz, S.; Bernstein, I.; Bertario, L.; Burn, J.; Capella, G.; Colas, C.; Engel, C.; Frayling, I.M.; Genuardi, M.; Heinimann, K.; Hes, F.J.; Hodgson, S.V.; Karagiannis, J.A.; Lalloo, F.; Lindblom, A.; Mecklin, J.P.; Moller, P.; Myrhoj, T.; Nagengast, F.M.; Parc, Y.; Leon, M.P. de; Renkonen-Sinisalo, L.; Sampson, J.R.; Stormorken, A.; Sijmons, R.H.; Tejpar, S.; Thomas, H.J.W.; Rahner, N.; Wijnen, J.T.; Jarvinen, H.J.; Moslein, G. & Mallorca Grp (2013), Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts, Gut 62(6): 812-823.
- Potjer, T.P.; Schot, I.; Langer, P.; Heverhagen, J.T.; Wasser, M.N.J.M.; Slater, E.P.; Kloppel, U.; Morreau, H.M.; Bonsing, B.A.; Cappel, W.H.D.; Bargello, M.; Gress, T.M.; Vasen, H.F.A.; Bartsch, D.K. & Leiden Familial Pancreatic Canc Gr (2013), Variation in Precursor Lesions of Pancreatic Cancer among High-Risk Groups, Clinical Cancer Research 19(2): 442-449.
- Bellido, F.; Guino, E.; Jagmohan-Changur, S.; Segui, N.; Pineda, M.; Navarro, M.; Lazaro, C.; Blanco, I.; Vasen, H.F.A.; Moreno, V.; Capella, G.; Wijnen, J.T. & Valle, L. (2013), Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome, European Journal of Human Genetics 21(5): 511-516.
- Botma, A.; Vasen, H.F.A.; Duijnhoven, F.J.B. van; Kleibeuker, J.H.; Nagengast, F.M. & Kampman, E. (2013), Dietary Patterns and Colorectal Adenomas in Lynch Syndrome The GEOLynch Cohort Study, Cancer 119(3): 512-521.
- Talseth-Palmer, B.A.; Wijnen, J.T.; Brenne, I.S.; Jagmohan-Changur, S.; Barker, D.; Ashton, K.A.; Tops, C.M.; Evans, T.J.; McPhillips, M.; Groombridge, C.; Suchy, J.; Kurzawski, G.; Spigelman, A.; Moller, P.; Morreau, H.M.; Wezel, T. van; Lubinski, J.; Vasen, H.F.A.; Scott, R.J. & Dutch Canc Genetics Grp (2013), Combined analysis of three lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
- Hennink, S.D.; Hofland, N.; Gopie, J.P.; Kaa, C. van der; Koning, K. de; Nielsen, M.; Tops, C.; Morreau, H.; Cappel, W.H.D.T.N.; Langers, A.M.J.; Hardwick, J.C.; Gaarenstroom, K.N.; Tollenaar, R.A.; Veenendaal, R.A.; Tibben, A.; Wijnen, J.; Heck, M. van; Asperen, C. van; Roukema, A.J.; Hommes, D.W.; Hes, F.J. & Vasen, H.F.A. (2013), Value-based healthcare in Lynch syndrome, Familial Cancer 12(2): 347-354.
- Miranda, N.F.C.C. de; Goudkade, D.; Jordanova, E.S.; Tops, C.M.J.; Hes, F.J.; Vasen, H.F.A.; Wezel, T. van & Morreau, H. (2012), Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases, Clinical Cancer Research 18(5): 1237-1245.
- Rahner, N.; Brockschmidt, F.F.; Steinke, V.; Kahl, P.; Becker, T.; Vasen, H.F.A.; Wijnen, J.T.; Tops, C.J.M.; Holinski-Feder, E.; Ligtenberg, M.J.L.; Spruijt, L.; Gorgens, H.; Stemmler, S.; Kloor, M.; Dietmaier, W.; Schumacher, J.; Nothen, M.M.; Propping, P. & Dutch Canc Genetics Grp (2012), Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors, Familial Cancer 11(1): 19-26.
- Crobach, S.; Wezel, T. van; Vasen, H.F. & Morreau, H. (2012), Ovarian metastases of colorectal and duodenal cancer in familial adenomatous polyposis, Familial Cancer 11(4): 671-673.
- Bulow, S.; Christensen, I.J.; Hojen, H.; Bjork, J.; Elmberg, M.; Jarvinen, H.; Lepisto, A.; Nieuwenhuis, M. & Vasen, H. (2012), Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis.
- Engel, C.; Loeffler, M.; Steinke, V.; Rahner, N.; Holinski-Feder, E.; Dietmaier, W.; Schackert, H.K.; Goergens, H.; Doeberitz, M.V.; Goecke, T.O.; Schmiegel, W.; Buettner, R.; Moeslein, G.; Letteboer, T.G.W.; Garcia, E.G.; Hes, F.J.; Hoogerbrugge, N.; Menko, F.H.; Os, T.A.M. van; Sijmons, R.H.; Wagner, A.; Kluijt, I.; Propping, P. & Vasen, H.F.A. (2012), Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome.
- Gopie, J.P.; Vasen, H.F.A. & Tibben, A. (2012), Surveillance for hereditary cancer: Does the benefit outweigh the psychological burden?-A systematic review.
- Nieuwenhuis, M.H.; Kets, C.M.; Murphy-Ryan, M.; Colas, C.; Moller, P.; Hes, F.J.; Hodgson, S.V.; Olderode-Berends, M.J.W.; Aretz, S.; Heinimann, K.; Gomez Garcia, E.B.; Douglas, F.; Spigelman, A.; Timshel, S.; Lindor, N.M. & Vasen, H.F.A. (2012), Is colorectal surveillance indicated in patients with PTEN mutations?
- Winkels, R.M.; Botma, A.; Duijnhoven, F.J.B. van; Nagengast, F.M.; Kleibeuker, J.H.; Vasen, H.F.A. & Kampman, E. (2012), Smoking Increases the Risk for Colorectal Adenomas in Patients With Lynch Syndrome, Gastroenterology 142(2): 241-247.
- Nieuwenhuis, M.H.; Douma, K.F.L.; Bleiker, E.M.A.; Aaronson, N.K.; Clevers, H. & Vasen, H.F.A. (2012), Clinical evidence for an association between familial adenomatous polyposis and type II diabetes.
- Haanstra, J.F.; Cappel, W.H.D.T.N.; Gopie, J.P.; Vecht, J.; Vanhoutvin, S.A.L.W.; Cats, A.; Zaag-Loonen, H.J. van der; Langers, A.M.J.; Bergmann, J.H.W.; Meeberg, P.C. van de; Dekker, E.; Kleibeuker, J.H.; Vasen, H.F.A.; Nagengast, F.M. & Duijvendijk, P. van (2012), Quality of Life After Surgery for Colon Cancer in Patients With Lynch Syndrome: Partial Versus Subtotal Colectomy, DISEASES OF THE COLON & RECTUM 55(6): 653-659.
- Mathers, J.C.; Movahedi, M.; Macrae, F.; Mecklin, J.P.; Moeslein, G.; Olschwang, S.; Eccles, D.; Evans, G.; Maher, E.R.; Bertario, L.; Bisgaard, M.L.; Dunlop, M.; Ho, J.W.C.; Hodgson, S.; Lindblom, A.; Lubinski, J.; Morrison, P.J.; Murday, V.; Ramesar, R.; Side, L.; Scott, R.J.; Thomas, H.J.W.; Vasen, H.; Gerdes, A.M.; Barker, G.; Crawford, G.; Elliott, F.; Pylvanainen, K.; Wijnen, J.; Fodde, R.; Lynch, H.; Bishop, D.T.; Burn, J. & CAPP 2 Investigators (2012), Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
- Heumen, B.W.H. van; Nieuwenhuis, M.H.; Goor, H. van; Mathus-Vliegen, L.M.H.; Dekker, E.; Gouma, D.J.; Dees, J.; Eijck, C.H.J. van; Vasen, H.F.A. & Nagengast, F.M. (2012), Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study, Surgery 151(5): 681-690.
- Nieuwenhuis, M.H.; Vogt, S.; Jones, N.; Nielsen, M.; Hes, F.J.; Sampson, J.R.; Aretz, S. & Vasen, H.F.A. (2012), Evidence for accelerated colorectal adenoma-carcinoma progression in MUTYH-associated polyposis?, Gut 61(5): 734-738.
- Talseth-Palmer, B.A.; Scott, R.J.; Vasen, H.F.A. & Wijnen, J.T. (2012), 8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome, European Journal of Human Genetics 20(5): 487-488.
- Vasen, H.F.A.; Wasser, M.; Mil, A. van; Tollenaar, R.A.; Konstantinovski, M.; Gruis, N.A.; Bergman, W.; Hes, F.J.; Hommes, D.W.; Offerhaus, G.J.A.; Morreau, H.; Bonsing, B.A. & Cappel, W.H.D.T.N. (2011), Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation, Gastroenterology 140(3): 850-856.
- Burn, J.; Bishop, D.T.; Chapman, P.D.; Elliott, F.; Bertario, L.; Dunlop, M.G.; Eccles, D.; Ellis, A.; Evans, D.G.; Fodde, R.; Maher, E.R.; Moslein, G.; Vasen, H.F.A.; Coaker, J.; Phillips, R.K.S.; Bulow, S.; Mathers, J.C. & Int CAPP Consortium (2011), A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis, Cancer Prevention Research 4(5): 655-665.
- Dinh, T.A.; Rosner, B.I.; Atwood, J.C.; Boland, C.R.; Syngal, S.; Vasen, H.F.A.; Gruber, S.B. & Burt, R.W. (2011), Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population, Cancer Prevention Research 4(1): 9-22.
- Meulen-de Jong, A.E. van der; Morreau, H.; Becx, M.C.J.M.; Crobach, L.F.S.J.; Haastert, M. van; Hove, W.R. ten; Kleibeuker, J.H.; Meijssen, M.A.C.; Nagengast, F.M.; Rijk, M.C.M.; Salemans, J.M.J.I.; Stronkhorst, A.; Tuynman, H.A.R.E.; Vecht, J.; Verhulst, M.L.; Cappel, W.H.D.T.N.; Walinga, H.; Weinhardt, O.K.; Westerveld, B.D.; Witte, A.M.C.; Wolters, H.J. & Vasen, H.F.A. (2011), High detection rate of adenomas in familial colorectal cancer, Gut 60(1): 73-76.
- Aretz, S.; Vasen, H.F.A. & Olschwang, S. (2011), Clinical utility gene card for: Familial adenomatous polyposis (FAP) and attenuated FAP (AFAP), European Journal of Human Genetics 19(7).
- Nielsen, M.; Morreau, H.; Vasen, H.F.A. & Hes, F.J. (2011), MUTYH-associated polyposis (MAP), Critical Reviews in Oncology/Hematology 79(1): 1-16.
- Douma, K.F.L.; Bleiker, E.M.A.; Vasen, H.F.A.; Gundy, C.M.; Gerritsma, M.A. & Aaronson, N.K. (2011), Psychological distress and quality of life of partners of individuals with familial adenomatous polyposis, Psycho-Oncology 20(2): 146-154.
- Burn, J.; Gerdes, A.M.; Macrae, F.; Mecklin, J.P.; Moeslein, G.; Olschwang, S.; Eccles, D.; Evans, D.G.; Maher, E.R.; Bertario, L.; Bisgaard, M.L.; Dunlop, M.G.; Ho, J.W.C.; Hodgson, S.V.; Lindblom, A.; Lubinski, J.; Morrison, P.J.; Murday, V.; Ramesar, R.; Side, L.; Scott, R.J.; Thomas, H.J.W.; Vasen, H.F.; Barker, G.; Crawford, G.; Elliott, F.; Movahedi, M.; Pylvanainen, K.; Wijnen, J.T.; Fodde, R.; Lynch, H.T.; Mathers, J.C.; Bishop, D.T. & CAPP2 Investigators (2011), Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial, Lancet 378(9809): 2081-2087.
- Nieuwenhuis, M.H.; Lefevre, J.H.; Bulow, S.; Jarvinen, H.; Bertario, L.; Kerneis, S.; Parc, Y. & Vasen, H.F.A. (2011), Family History, Surgery, and APC Mutation Are Risk Factors for Desmoid Tumors in Familial Adenomatous Polyposis: An International Cohort Study, Diseases of the Colon and Rectum 54(10): 1229-1234.
- Nieuwenhuis, M.H.; Mathus-Vliegen, E.M.; Baeten, C.G.; Nagengast, F.M.; Bijl, J. van der; Dalsen, A.D. van; Kleibeuker, J.H.; Dekker, E.; Langers, A.M.; Vecht, J.; Peters, F.T.; Dam, R. van; Gemert, W.G. van; Stuifbergen, W.N.; Schouten, W.R.; Gelderblom, H. & Vasen, H.F.A. (2011), Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients, British Journal of Cancer 104(1): 37-42.
- Vasen, H.F.A. & Cappel, W.H.D.T.N. (2011), Lynch syndrome-how should colorectal cancer be managed?, Nature Reviews Gastroenterology and Hepatology 8(4): 184-186.
- Nieuwenhuis, M.H.; Casparie, M.; Mathus-Vliegen, L.M.H.; Dekkers, O.M.; Hogendoorn, P.C.W. & Vasen, H.F.A. (2011), A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses, International Journal of Cancer 129(1): 256-261.
- Douma, K.F.L.; Bleiker, E.M.A.; Vasen, H.F.A.; Gundy, C.M. & Aaronson, N.K. (2011), Quality of life and consequences for daily life of familial adenomatous polyposis (FAP) family members, Colorectal Disease 13(6): 669-677.
- Nieuwenhuis, M. & Vasen, H.F.A. (2011), Reply: Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients, British Journal of Cancer 104(7): 1237-1237.
- Capelle, L.G.; Grieken, N.C.T. van; Lingsma, H.F.; Steyerberg, E.W.; Klokman, W.J.; Bruno, M.J.; Vasen, H.F.A. & Kuipers, E.J. (2010), Risk and Epidemiological Time Trends of Gastric Cancer in Lynch Syndrome Carriers in The Netherlands, Gastroenterology 138(2): 487-492.
- Douma, K.F.L.; Aaronson, N.K.; Vasen, H.F.A.; Gerritsma, M.A.; Gundy, C.M.; Janssen, E.P.A.; Vriends, A.H.J.T.; Cats, A.; Verhoef, S. & Bleiker, E.M.A. (2010), Psychological distress and use of psychosocial support in familial adenomatous polyposis, Psycho-Oncology 19(3): 289-298.
- Nieuwenhuis, M.H.; Douma, K.F.; Bleiker, E.M.; Bemelman, W.A.; Aaronson, N.K. & Vasen, H.F. (2010), Female Fertility After Colorectal Surgery for Familial Adenomatous Polyposis A Nationwide Cross-sectional Study, Annals of Surgery 252(2): 341-344.
- Douma, K.F.L.; Bleiker, E.M.A.; Aaronson, N.K.; Cats, A.; Gerritsma, M.A.; Gundy, C.M. & Vasen, H.F.A. (2010), Long-term compliance with endoscopic surveillance for familial adenomatous polyposis, Colorectal Disease 12(12): 1198-1207.
- Grindedal, E.M.; Renkonen-Sinisalo, L.; Vasen, H.; Evans, G.; Sala, P.; Blanco, I.; Gronwald, J.; Apold, J.; Eccles, D.M.; Sanchez, A.A.; Sampson, J.; Jarvinen, H.J.; Bertario, L.; Crawford, G.C.; Stormorken, A.T.; Maehle, L. & Moller, P. (2010), Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds, Journal of Medical Genetics 47(2): 99-102.
- Nielsen, M.; Steenbergen, L.N. van; Jones, N.; Vogt, S.; Vasen, H.F.A.; Morreau, H.; Aretz, S.; Sampson, J.R.; Dekkers, O.M.; Janssen-Heijnen, M.L.G. & Hes, F.J. (2010), Survival of MUTYH-Associated Polyposis Patients With Colorectal Cancer and Matched Control Colorectal Cancer Patients, JNCI: Journal of the National Cancer Institute 102(22): 1724-1730.
- Pijpe, A.; Manders, P.; Brohet, R.M.; Collee, J.M.; Verhoef, S.; Vasen, H.F.A.; Hoogerbrugge, N.; Asperen, C.J. van; Dommering, C.; Ausems, M.G.E.M.; Aalfs, C.M.; Gomez-Garcia, E.B.; van't Veer, L.J.; Leeuwen, F.E. van; Rookus, M.A. & HEBON (2010), Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers, Breast Cancer Research and Treatment 120(1): 235-244.
- Miclea, R.L.; Karperien, M.; Langers, A.M.; Robanus-Maandag, E.C.; Lierop, A. van; Hiel, B. van der; Stokkel, M.P.; Ballieux, B.E.; Oostdijk, W.; Wit, J.M.; Vasen, H.F. & Hamdy, N.A. (2010), APC Mutations Are Associated With Increased Bone Mineral Density in Patients With Familial Adenomatous Polyposis, Journal of Bone and Mineral Research 25(12): 2348-2356.
- Middeldorp, A.; Jagmohan-Changur, S.C.; Klift, H.M. van der; Puijenbroek, M. van; Houwing-Duistermaat, J.J.; Webb, E.; Houlston, R.; Tops, C.; Vasen, H.F.A.; Devilee, P.; Morreau, H.; Wezel, T. van & Wijnen, J. (2010), Comprehensive Genetic Analysis of Seven Large Families with Mismatch Repair Proficient Colorectal Cancer, Genes, Chromosomes and Cancer 49(6): 539-548.
- Beggs, A.D.; Latchford, A.R.; Vasen, H.F.A.; Moslein, G.; Alonso, A.; Aretz, S.; Bertario, L.; Blanco, I.; Bulow, S.; Burn, J.; Capella, G.; Colas, C.; Friedl, W.; Moller, P.; Hes, F.J.; Jarvinen, H.; Mecklin, J.P.; Nagengast, F.M.; Parc, Y.; Phillips, R.K.S.; Hyer, W.; Leon, M.P. de; Renkonen-Sinisalo, L.; Sampson, J.R.; Stormorken, A.; Tejpar, S.; Thomas, H.J.W.; Wijnen, J.T.; Clark, S.K. & Hodgson, S.V. (2010), Peutz-Jeghers syndrome: a systematic review and recommendations for management, Gut 59(7): 975-986.
- Vasen, H.F.A.; Moslein, G.; Alonso, A.; Aretz, S.; Bernstein, I.; Bertario, L.; Blanco, I.; Bulow, S.; Burn, J.; Capella, G.; Colas, C.; Engel, C.; Frayling, I.; Rahner, N.; Hes, F.J.; Hodgson, S.; Mecklin, J.P.; Moller, P.; Myrhoj, T.; Nagengast, F.M.; Parc, Y.; Leon, M.P. de; Renkonen-Sinisalo, L.; Sampson, J.R.; Stormorken, A.; Tejpar, S.; Thomas, H.J.W.; Wijnen, J.; Lubinski, J.; Jarvinen, H.; Claes, E.; Heinimann, K.; Karagiannis, J.A.; Lindblom, A.; Dove-Edwin, I. & Muller, H. (2010), Recommendations to improve identification of hereditary and familial colorectal cancer in Europe, Familial Cancer 9(2): 109-115.
- Wasielewski, M.; Out, A.A.; Vermeulen, J.; Nielsen, M.; Ouweland, A. van den; Tops, C.M.J.; Wijnen, J.T.; Vasen, H.F.A.; Weiss, M.M.; Klijn, J.G.M.; Devilee, P.; Hes, F.J. & Schutte, M. (2010), Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer, Breast Cancer Research and Treatment 124(3): 635-641.
- Vasen, H.F.A.; Abdirahman, M.; Brohet, R.; Langers, A.M.J.; Kleibeuker, J.H.; Kouwen, M. van; Koornstra, J.J.; Boot, H.; Cats, A.; Dekker, E.; Sanduleanu, S.; Poley, J.W.; Hardwick, J.C.H.; Cappel, W.H.D.T.; Meulen-de Jong,AE van der; Tan, T.G.; Jacobs, M.A.J.M.; Mohamed, F.L.A.; Boer, S.Y. de; Meeberg, P.C. van de; Verhulst, M.L.; Salemans, J.M.; Bentem, N. van; Westerveld, B.D.; Vecht, J. & Nagengast, F.M. (2010), One to 2-Year Surveillance Intervals Reduce Risk of Colorectal Cancer in Families With Lynch Syndrome, Gastroenterology 138(7): 2300-2306.
- Klift, H.M. van der; Tops, C.M.J.; Bik, E.C.; Boogaard, M.W.; Borgstein, A.M.; Hansson, K.B.M.; Ausems, M.G.E.M.; Garcia, E.G.; Green, A.; Hes, F.J.; Izatt, L.; Hest, L.P. van; Alonso, A.M.; Vriends, A.H.J.T.; Wagner, A.; Zelst-Stams, W.A.G. van; Vasen, H.F.A.; Morreau, H.; Devilee, P. & Wijnen, J.T. (2010), Quantification of Sequence Exchange Events between PMS2 and PMS2CL Provides a Basis for Improved Mutation Scanning of Lynch Syndrome Patients, Human Mutation 31(5): 578-587.
- Baglietto, L.; Lindor, N.M.; Dowty, J.G.; White, D.M.; Wagner, A.; Garcia, E.B.G.; Vriends, A.H.J.T.; Cartwright, N.R.; Barnetson, R.A.; Farrington, S.M.; Tenesa, A.; Hampel, H.; Buchanan, D.; Arnold, S.; Young, J.; Walsh, M.D.; Jass, J.; Macrae, F.; Antill, Y.; Winship, I.M.; Giles, G.G.; Goldblatt, J.; Parry, S.; Suthers, G.; Leggett, B.; Butz, M.; Aronson, M.; Poynter, J.N.; Baron, J.A.; Marchand, L. le; Haile, R.; Gallinger, S.; Hopper, J.L.; Potter, J.; Chapelle, A. de la; Vasen, H.F.; Dunlop, M.G.; Thibodeau, S.N.; Jenkins, M.A. & Dutch Lynch Syndrome Study Grp (2010), Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers, JNCI: Journal of the National Cancer Institute 102(3): 193-201.
- Botma, A.; Nagengast, F.M.; Braem, M.G.M.; Hendriks, J.C.M.; Kleibeuker, J.H.; Vasen, H.F.A. & Kampman, E. (2010), Body Mass Index Increases Risk of Colorectal Adenomas in Men With Lynch Syndrome: The GEOLynch Cohort Study, Journal of Clinical Oncology 28(28): 4346-4353.
- Douma, K.F.L.; Aaronson, N.K.; Vasen, H.F.A.; Verhoef, S.; Gundy, C.M. & Bleiker, E.M.A. (2010), Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis, European Journal of Human Genetics 18(2): 186-193.
- Drost, M.; Zonneveld, J.B.M.; Dijk, L. van; Morreau, H.; Tops, C.M.; Vasen, H.F.A.; Wijnen, J.T. & Wind, N. de (2010), A Cell-Free Assay for the Functional Analysis of Variants of the Mismatch Repair Protein MLH1, Human Mutation 31(3): 247-253.
- Nielsen M, de Miranda NFCC, van Puijenbroek M, Jordanova ES, Middeldorp A, van Wezel T, van Eijk R, Tops CMJ, Vasen HFA & Hes FJ (2009), Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas, BMC Cancer 9.
- Middeldorp A, Jagmohan-Changur S, van Eijk R, Tops C, Devilee P, Vasen HFA, Hes FJ, Houlston R, Tomlinson I, Houwing-Duistermaat JJ, Wijnen JT, Morreau H & van Wezel T (2009), Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort, Cancer Epidemiology, Biomarkers and Prevention 18(11): 3062-3067.
- Vasen HFA, van der Meulen-de Jong AE, Cappel WHDTN & Oliveira J (2009), Familial colorectal cancer risk: ESMO Clinical Recommendations, Annals of Oncology 20: 51-53.
- Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, Steinke V, Vasen HF, Propping P & Sampson JR (2009), Expanded Extracolonic Tumor Spectrum in MUTYH-Associated Polyposis, Gastroenterology 137(6): 1976-1985.
- Vasen HFA (2009), Genetic Testing in Gastroenterology Preface, Best Practice and Research: Clinical Gastroenterology 23(2): 125-126.
- Nieuwenhuis MH, Bulow S, Bjork J, Jarvinen HJ, Bulow C, Bisgaard ML & Vasen HFA (2009), Genotype Predicting Phenotype in Familial Adenomatous Polyposis: A Practical Application to the Choice of Surgery, Diseases of the Colon and Rectum 52(7): 1259-1263.
- Grindedal EM, Blanco I, Stormorken A, Maehle L, Clark N, Gonzalez S, Capella G, Vasen H, Burn J & Moller P (2009), High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers, Familial Cancer 8(2): 145-151.
- Jones N, Vogt S, Nielsen M, Christian D, Wark PA, Eccles D, Edwards E, Evans DG, Maher ER, Vasen HF, Hes FJ, Aretz S & Sampson JR (2009), Increased Colorectal Cancer Incidence in Obligate Carriers of Heterozygous Mutations in MUTYH, Gastroenterology 137(2): 489-494.
- Nielsen M, Joerink-Van de Beld MC, Jones N, Vogt S, Tops CM, Vasen HFA, Sampson JR, Aretz S & Hes FJ (2009), Analysis of MUTYH Genotypes and Colorectal Phenotypes in Patients With MUTYH-Associated Polyposis, Gastroenterology 136(2): 471-476.
- Evans DG, Gaarenstroom KN, Stirling D, Shenton A, Maehle L, Dorum A, Steel M, Lalloo F, Apold J, Porteous ME, Vasen HFA, van Asperen CJ & Moller P (2009), Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers, Journal of Medical Genetics 46(9): 593-597.
- Vasen HF, Möslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Rahner N, Hes FJ, Hodgson S, Mecklin JP, Møller P, Myrhøj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J, Lubinski J, Järvinen H, Claes E, Heinimann K, Karagiannis JA, Lindblom A, Dove-Edwin I & Müller H (2009), Recommendations to improve identification of hereditary and familial colorectal cancer in Europe., Familial Cancer.
- de Miranda NFCC, Nielsen M, Pereira D, van Puijenbroek M, Vasen HF, Hes FJ, van Wezel T & Morreau H (2009), MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers, Journal of Pathology 219(1): 69-76.
- Wijnen JT, Brohet RM, Van Eijk R, Jagmohan-Changur S, Middeldorp A, Tops CM, Van Puijenbroek M, Ausems MGEM, Garcia EG & Hes FJ (2009), Chromosome 8q23.3 and 11q23.1 Variants Modify Colorectal Cancer Risk in Lynch Syndrome, Gastroenterology 136(1): 131-137.
- Vasen H.F.A. & Kate G.L. ten (2008), Small bowel cancer: Should relatives be screened for Lynch syndrome? - Reply, Gut 57(1): 140-140.
- Middeldorp A, van Puijenbroek M, Nielsen M, Corver WE, Jordanova ES, ter Haar N, Tops CMJ, Vasen HFA, Lips EH, van Eijk R, Hes FJ, Oosting J, Wijnen J, van Wezel T & Morreau H (2008), High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas, Journal of Pathology 216(1).
- Vasen HFA & Ten Kate GL (2008), Small bowel cancer: Should relatives be screened for Lynch syndrome? - Reply, Gut 57(1).
- Vasen HFA, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Jarvinen H, Mecklin JP, Moller P, Myrhoi T, Nagengast FM, Parc Y, Phillips R, Clark SK, de Leon MP, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJW & Wijnen J (2008), Guidelines for the clinical management of familial adenomatous polyposis (FAP), Gut 57(5).
- Douma KFL, Aaronson NK, Vasen HFA & Bleiker EMA (2008), Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature, Psycho-Oncology 17(8).
- van Puijenbroek M, Nielsen M, Tops CMJ, Halfwerk H, Vasen HFA, Weiss MM, van Wezel T, Hes FJ & Morreau H (2008), Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue, Clinical Cancer Research 14(1).
- de Snoo FA, Rledijk SR, van Mil AM, Bergman W, ter Huurne JAC, Timman R, Bertina W, Gruis NA, Vasen HFA, van Haeringen A, Breuning MH & Tibben A (2008), Genetic testing in familial melanoma: uptake and implications, Psycho-Oncology 17(8).
- van Puijenbroek M, Middeldorp A, Tops CMJ, van Eijk R, van der Klift HM, Vasen HFA, Wijnen JT, Hes FJ, Oosting J, van Wezel T & Morreau H (2008), Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas, Familial Cancer 7(4).
- Koornstra JJ, Kleibeuker JH & Vasen HFA (2008), Small-bowel cancer in Lynch syndrome: is it time for surveillance?, Lancet Oncology 9(9).
- Nieuwenhuis MH, Cappel WDVTN, Botma A, Nagengast FM, Kleibeuker JH, Mathus-Vliegen EMH, Dekker E, Dees J, Wijnen J & Vasen HFA (2008), Desmoid tumors in a Dutch cohort of patients with familial adenomatous polyposis, Clinical Gastroenterology and Hepatology 6(2).
- Bulow S, Bulow C, Vasen H, Jarvinen H, Bjork J & Christensen IJ (2008), Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis, Diseases of the Colon and Rectum 51(9).
- de Snoo FA, Bishop DT, Bergman W, van Leeuwen I, van der Drift C, van Nieuwpoort FA, Out-Luiting CJ, Vasen HF, ter Huurne JAC, Frants RR, Willemze R, Breuning MH & Gruis NA (2008), Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families, Clinical Cancer Research 14(21).
- Langers AMJ, Cappell WHD, Veenendaal RA, Bonsing BA, Hardwick JCH & Vasen HFA (2008), Double balloon endoscopy for detection of small-bowel adenomas in familial adenomatous polyposis after pancreaticoduodenectomy according to Whipple, Endoscopy 40(9).
- Oldenburg RA, Kroeze-Jansema KHG, Houwing-Duistermaat JJ, Bayley JP, Dambrot C, van Asperen CJ, van den Ouweland AMW, Bakker B, van Beers EH, Nederlof PM, Vasen H, Hoogerbrugge N, Cornelisse CJ, Meijers-Heijboer H & Devilee P (2008), Genome-wide linkage scan in dutch hereditary non-BRCA 1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus, Genes, Chromosomes and Cancer 47(11).
- Hes FJ, Nielsen M, Bik EC, Konvalinka D, Wijnen JT, Bakker E, Vasen HFA, Breuning MH & Tops CMJ (2008), Somatic APC mosaicism: an underestimated cause of polyposis coli, Gut 57(1).
- Wasielewski M, Vasen H, Wijnen J, Hooning M, Dooijes D, Tops C, Klijn JGM, Meijers-Heijboer H & Schutte M (2008), CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer, Clinical Cancer Research 14(15).
- Watson P, Vasen HFA, Mecklin JP, Bernstein I, Aarnio M, Jarvinen HJ, Myrhoj T, Sunde L, Wijnen JT & Lynch HT (2008), The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome, International Journal of Cancer 123(2).
- Vasen HFA (2008), Can the identification of high risk groups increase the effectiveness of colon cancer screening programmes?, Zeitschrift f�r Gastroenterologie 46.
- Burn J, Bishop DT, Mecklin JP, Macrae F, Moslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JWC, Vasen HFA, Side L, Thomas HJW, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT & Mathers JC (2008), Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome, New England Journal of Medicine 359(24).
- Friederich, P.; Jong, A.E. de; Mathus-Vliegen, L.M.; Dekker, E.; Krieken, H.H.; Dees, J.; Nagengast, F.M. & Vasen, H.F.A. (2008), Risk of Developing Adenomas and Carcinomas in the Ileal Pouch in Patients With Familial Adenomatous Polyposis, Clinical Gastroenterology and Hepatology 6(11).
- Nieuwenhuis M.H. & Vasen H.F.A. (2007), Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature, Critical Reviews in Oncology Hematology 61(2): 153-161.
- Nieuwenhuis MH & Vasen HFA (2007), Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature, Critical Reviews in Oncology/Hematology 61(2).
- Middeldorp A, Jagmohan-Changur S, Helmer Q, van der Klift HM, Tops CMJ, Vasen HFA, Devilee P, Morreau H, Houwing-Duistermaat JJ, Wijnen JT & van Wezel T (2007), A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancer, BMC Cancer 7.
- Nielsen M, Bik E, Hes FJ, Breuning MH, Vasen HFA, Bakker E, Tops CMJ & Weiss MM (2007), Genotype-phenotype correlations in 19 Dutch cases with APC gene deletions and a literature review, European Journal of Human Genetics 15(10).
- Nielsen M, Hes FJ, Vasen HFA & van den Hout WB (2007), Cost-utility analysis of genetic screening in families of patients with germline MUTYH mutations, BMC Medical Genetics 8.
- Koornstra, J.J.; Wesseling, J.; Jong, A.E. de; Vasen, H.F.A.; Kleibeuker, J.H. & Haagsma, E.B. (2007), Increased risk of colorectal neoplasia in asymptomatic liver transplant recipients, Gut 56(6).
- Nielsen M, Hes FJ, Nagengast FM, Weiss MM, Mathus-Vliegen EM, Morreau H, Breuning MH, Wijnen JT, Tops CMJ & Vasen HFA (2007), Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis, Clinical Genetics 71(5).
- Diergaarde B, Braam H, Vasen HF, Nagengast FM, Van Muijen GNP, Kok FJ & Kampman E (2007), Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer, Clinical Gastroenterology and Hepatology 5(6).
- Vasen HFA, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Mecklin JP, Moller P, Nagengast F, Parc Y, Renkonen-Sinisalo L, Sampson JR, Stormorken A & Wijnen J (2007), Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer), Journal of Medical Genetics 44(6).
- Vasen HFA (2007), Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
- Nieuwenhuis MH, Mathus-Vliegen LM, Slors FJ, Griffioen G, Nagengast FM, Schouten WR, Kleibeuker JH & Vasen HFA (2007), Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis, Clinical Gastroenterology and Hepatology 5(3).
- van Dijk DA, Oostindier MJ, Kloosterman-Boele WM, Krijnen P & Vasen HFA (2007), Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data, Familial Cancer 6(1).
- Puijenbroek, M. van; Nielsen, M.; Reinards, T.H.C.M.; Weiss, M.M.; Wagner, A.; Hendriks, Y.M.C.; Vasen, H.F.A.; Tops, C.M.J.; Wijnen, J.; Wezel, T. van; Hes, F.J. & Morreau, H. (2007), The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family, Familial Cancer 6(1).
- Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, Porteous ME, Jakubowska A, Lubinski J, Gronwald J, Spurdle AB, , Schmutzler R, Versmold B, Engel C, Meindl A, Sutter C, Horst J, Schaefer D, Offit K, Kirchhoff T, Andrulis IL, Ilyushik E, Glendon G, Devilee P, Vreeswijk MPG, Vasen HFA, Borg A, Backenhorn K, Struewing JP, Greene MH, Neuhausen SL, Rebbeck TR, Nathanson K, Domchek S, Wagner T, Garber JE, Szabo C, Zikan M, Foretova L, Olson JE, Sellers TA, Lindor N, Ll HN, Tommiska J, Aittomaki K, Hamann U, Rashid MU, Torres D, Simard J, Durocher F, Guenard F, Lynch HT, Isaacs C, Weitzel J, Olopade OI, Narod S, Daly MB, Godwin AK, Tomlinson G, Easton DF, Chenevix-Trench G & Antoniou AC (2007), AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A consortium of investigators of modifiers of BRCA1/2 study, Cancer Epidemiology, Biomarkers and Prevention 16(7).
- Koornstra JJ & Vasen HF (2007), Surveillance colonoscopy practice in Lynch syndrome in the Netherlands: A nationwide survey, World Journal of Gastroenterology 13(34).
- ten Kate GL, Kleibeuker JH, Nagengast FM, Craanen M, Cats A, Menko FH & Vasen HFA (2007), Is surveillance of the small bowel indicated for Lynch syndrome families?, Gut 56(9).
- Hendriks, Y.M.C.; Jong, A.E. de; Morreau, H.; Tops, C.M.J.; Vasen, H.F.; Wijnen, J.T.; Breuning, M.H. & Brocker-Vriends, A.H.J.T. (2006), Diagnostic approach and management of Lynch syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A guide for clinicians, CA: A Cancer Journal for Clinicians 56(4).
- Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, Hopper JL, Giles GG, McCredie MRE, Buys S, Andrulis I, Senie R, Goldgar DE, Oldenburg R, Kroeze-Jansema K, Kraan J, Meijers-Heijboer H, Klijn JGM, van Asperen C, van Leeuwen I, Vasen HFA, Cornelisse CJ, Devilee P, Baskcomb L, Seal S, Barfoot R, Mangion J, Hall A, Edkins S, Rapley E, Wooster R, Chang-Claude J, Eccles D, Evans DG, Futreal PA, Nathanson KL, Weber BL, Rahman N & Stratton MR (2006), A genome wide linkage search for breast cancer susceptibility genes, Genes, Chromosomes and Cancer 45(7).
- Hendriks, Y.M.C.; Jagmohan-Changur, S.; Klift, H.M. van der; Morreau, H.; Puijenbroek, M. van; Tops, C.; Os, T. van; Wagner, A.; Ausems, M.G.F.M.; Gomez, E.; Breuning, M.H.; Brocker-Vriends, A.H.J.T.; Vasen, H.F.A. & Wijnen, J.T. (2006), Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome), Gastroenterology 130(2).
- Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HFA, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ & Devilee P (2006), Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping, Clinical Cancer Research 12(6).
- Vasen HF & Cappel WHDTN (2006), An evidence-based review on surveillance for Lynch syndrome, Diseases of the Colon and Rectum 49(11).
- Park JG, Kim DW, Hong CW, Nam BH, Shin YK, Hong SH, Kim IJ, Lim SB, Aronson M, Bisgaard ML, Brown GJ, Burn J, Chow E, Conrad P, Douglas F, Dunlop M, Ford J, Greenblatt MS, Heikki J, Heinimann K, Lynch EL, Macrae F, McKinnon WC, Moeslein G, Rossi BM, Rozen P, Schofield L, Vaccaro C, Vasen H, Velthuizen M, Viel A & Wijnen J (2006), Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study, Clinical Cancer Research 12(11).
- Jong, A.E. de; Hendriks, Y.M.C.; Kleibeuker, J.H.; Boer, S.Y. de; Cats, A.; Griffioen, G.; Nagengast, F.M.; Nelis, F.G.; Rookus, M.A. & Vasen, H.F.A. (2006), Decrease in mortality in Lynch syndrome families because of surveillance, Gastroenterology 130(3).
- Jong, A.E. de & Vasen, H.F.A. (2006), The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands, Netherlands Journal of Medicine 64(10).
- Nielsen M, Poley JW, Verhoef S, van Puijenbroek M, Weiss MM, Burger GT, Dommering CJ, Vasen HFA, Kuipers EJ, Wagner A, Morreau H & Hes FJ (2006), Duodenal carcinoma in MUTYH-associated polyposis, Journal of Clinical Pathology 59(11).
- Jong, A.E. de; Nagengast, F.M.; Kleibeuker, J.H.; Meeberg, P.C. van de; Wijk, H.J. van; Cats, A.; Griffioen, G. & Vasen, H.F.A. (2006), What is the appropriate screening protocol in Lynch syndrome?, Familial Cancer 5(4).
- Dove-Edwin, I.; Jong, A.E. de; Adams, J.; Mesher, D.; Lipton, L.; Sasieni, P.; Vasen, H.F.A. & Thomas, H.J.W. (2006), Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome, Gastroenterology 130(7).
- Nielsen, M.; Weiss, M.M.; Vasen, H.F. & Hes, F.J. (2005), Van gen naar ziekte, Nederlands Tijdschrift voor Geneeskunde 149(53): 2970-2.
- Mesters I, Ausems M, Eichhorn S & Vasen H (2005), Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study, Familial Cancer 4(2).
- Vasen HFA (2005), Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)], Familial Cancer 4(3).
- Vasen HFA & Boland CR (2005), Progress in genetic testing, classification, and identification of Lynch syndrome, Journal of the American Medical Association 293(16).
- Nielsen M, Franken PF, Reinards THCM, Weiss MM, Wagner A, van der Klift H, Kloosterman S, Houwing-Duistermaat JJ, Aalfs CM, Ausems MGEM, Brocker-Vriends AHJT, Garcia EBG, Hoogerbrugge N, Menko FH, Sijmons RH, Verhoef S, Kuipers EJ, Morreau H, Breuning MH, Tops CMJ, Wijnen JT, Vasen HFA, Fodde R & Hes FJ (2005), Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP), Journal of Medical Genetics 42(9).
- van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HFA, Ausems MGEM, Menko FH, Garcia EBG, Klijn JGM, Hogervorst FBL, van Houwelingen JC, van't Veer LJ, Rookus MA & van Leeuwen FE (2005), Cancer risks in BRCA2 families: estimates for sites other than breast and ovary, Journal of Medical Genetics 42(9).
- Warlam-Rodenhuis CC, Koot VCM, van der Luijt RB, Vasen HFA & Ausems MGEM (2005), A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients, European Journal of Cancer 41(10).
- Bleiker EMA, Menko FH, Taal BG, Kluijt I, Wever LDV, Gerritsma MA, Vasen HFA & Aaronson NK (2005), Screening behavior of individuals at high risk for colorectal cancer, Gastroenterology 128(2).
- Bian Y, Caldes T, Wijnen J, Franken P, Vasen H, Kaklamani V, Nafa K, Peterlongo P, Ellis N, Baron JA, Burn J, Moeslein G, Morrison PJ, Chen Y, Ahsan H, Watson P, Lynch HT, de la Chapelle A, Fodde R & Pasche B (2005), TGFBR1*6A may contribute to hereditary colorectal cancer, Journal of Clinical Oncology 23(13).
- Vasen HFA & Cappel WHDTN (2005), An alternative to prophylactic colectomy for colon cancer prevention in HNPCC syndrome, Gut 54(10).
- van der Klift H, Wijnen J, Wagner A, Verkuilen P, Tops C, Otway R, Kohonen-Corish M, Vasen H, Oliani C, Barana D, Moller P, DeLozier-Blanchet C, Hutter P, Foulkes W, Lynch H, Burn J, Moslein G & Fodde R (2005), Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary Nonpolyposis colorectal cancer (HNPCC), Genes, Chromosomes and Cancer 44(2).
- Kievit W, de Bruin JHFM, Adang EMM, Severens JL, Kleibeuker JH, Sijmons RH, Ruers TJ, Nagengast FM, Vasen HFA, van Krieken JHJM, Ligtenberg MJL & Hoogerbrugge N (2005), Cost effectiveness of a new strategy to identify HNPCC patients, Gut 54(1).
- Jong, A.E. de; Morreau, H.; Nagengast, F.M.; Mathus-Vliegen, E.M.H.; Kleibeuker, J.H.; Griffioen, G.; Cats, A. & Vasen, H.F.A. (2005), Prevalence of adenomas among young individuals at average risk for colorectal cancer.
- Quehenberger F, Vasen HFA & van Houwelingen HC (2005), Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment, Journal of Medical Genetics 42(6).
- Wagner A, van Kessel I, Kriege MG, Tops CMJ, Wijnen JT, Vasen HFA, van der Meer CA, van Oostrom IIH & Meijers-Heijboer H (2005), Long term follow-up of HNPCC gene mutation carriers: Compliance with screening and satisfaction with counseling and screening procedures, Familial Cancer 4(4): 295-300.
- Vasen HFA, Tesfay E, Boonstra H, Mourits MJE, Rutgers E, Verheyen R, Oosterwijk J & Beex L (2005), Early detection of breast and ovarian cancer in families with BRCA mutations, European Journal of Cancer 41(4).
- Cappel WHDN, Meulenbeld HJ, Kleibeuker JH, Nagengast FM, Menko FH, Griffioen G, Cats A, Morreau H, Gelderblom H & Vasen HFA (2004), Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer, International Journal of Cancer 109(3).
- Jong, A.E. de; Morreau, H.; Puijenbroek, M. van; Eilers, P.H.C.; Wijnen, J.; Nagengast, F.M.; Griffioen, G.; Cats, A.; Menko, F.H.; Kleibeuker, J.H. & Vasen, H.F.A. (2004), The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC, Gastroenterology 126(1).
- Oldenburg RA, Cappel WHD, van Puijenbroek M, van den Ouweland A, Bakker E, Griffioen G, Devilee P, Cornelisse CJ, Meijers-Heijboer H, Vasen HFA & Morreau H (2004), Extending the p16-Leiden tumour spectrum by respiratory tract tumours, Journal of Medical Genetics 41(3).
- Vasen, H.F.A.; Hendriks, Y.; Jong, A.E. de; Puijenbroek, M. van; Tops, C.; Brocker-Vriends, A.H.J.T.; Wijnen, J.T. & Morreau, H. (2004), Identification of HNPCC by molecular analysis of colorectal and endometrial tumors, Disease Markers 20(4-5).
- Peltomaki P & Vasen H (2004), Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/INSiGHT mutation database, Disease Markers 20(4-5).
- Bulow S, Bjork J, Christensen IJ, Fausa O, Jarvinen H, Moesgaard F & Vasen HFA (2004), Duodenal adenomatosis in familial adenomatous polyposis, Gut 53(3).
- Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HFA, Hawk ET, Barrett JC, Freedman AN & Srivastava S (2004), Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability, JNCI: Journal of the National Cancer Institute 96(4).
- Hendriks, Y.M.C.; Wagner, A.; Morreau, H.; Menko, F.; Stormorken, A.; Quehenberger, F.; Sandkuijl, L.; Moller, P.; Genuardi, M.; Houwelingen, H. van; Tops, C.; Puijenbroek, M. van; Verkuijlen, P.; Kenter, G.; Mil, A. van; Meijers-Heijboer, H.; Tan, G.B.; Breuning, M.H.; Fodde, R.; Wijnen, J.T.; Brocker-Vriends, A.H.J.T. & Vasen, H. (2004), Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillance, Gastroenterology 127(1).
- Jong, A.E. de; Puijenbroek, M. van; Hendriks, Y.; Tops, C.; Wijnen, J.; Ausems, M.G.E.M.; Meijers-Heijboer, H.; Wagner, A.; Os, T.A.M. van; Brocker-Vriends, A.H.J.T.; Vasen, H.F.A. & Morreau, H. (2004), Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer, Clinical Cancer Research 10(3).
- Cappel WHDTN, Buskens E, van Duijvendijk P, Cats A, Menko FH, Griffioen G, Slors JF, Nagengast FM, Kleibeuker JH & Vasen HFA (2003), Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect, Gut 52(12).
- Cappel WHDTN, Jarvinen HJ, Bjork J, Berk T, Griffioen G & Vasen HFA (2003), Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis, British Journal of Surgery 90(6).
- Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JGM, Hoogerbrugge N, Ligtenberg MJL, van Asperen CJ, Vasen HFA, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ & Devilee P (2003), The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families, Cancer Research 63(23).
- Bleiker EMA, Menko FH, Taal BG, Kluijt I, Wever LDV, Gerritsma MA, Vasen HFA & Aaronson NK (2003), Experience of discharge from colonoscopy of mutation negative HNPCC family members, Journal of Medical Genetics 40(5).
- de Leeuw WJF, van Puijenbroek M, Tollenaar RAEM, Cornelisse CJ, Vasen HFA & Morreau H (2003), Correspondence re: A. Muller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res., 62 : 1014-1019, 2002., Cancer Research 63(5).
- Thomas HJW, Dove-Edwin I, Goff S & Vasen HFA (2003), The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma - Author reply, Cancer 98(8).
- Jagmohan-Changur S, Poikonen T, Vilkki S, Launonen V, Wikman F, Orntoft TF, Moller P, Vasen H, Tops C, Kolodner RD, Mecklin JP, Jarvinen H, Bevan S, Houlston RS, Aaltonen LA, Fodde R, Wijnen J & Karhu A (2003), EXO1 variants occur commonly in normal population: Evidence against a role in hereditary nonpolyposis colorectal cancer, Cancer Research 63(1).
- Cappel WHDTN, Lagendijk MAC, Lamers CBHW, Morreau H & Vasen HFA (2003), Surveillance for familial pancreatic cancer, Scandinavian Journal of Gastroenterology 38.
- Hendriks, Y.; Franken, P.; Dierssen, J.W.; Leeuw, J. de; Wijnen, J.; Dreef, E.; Tops, C.; Breuning, M.; Brocker-Vriends, A.; Vasen, H.; Fodde, R. & Morreau, H. (2003), Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors, The American Journal of Pathology 162(2).
- Meijers-Heijboer H, Wijnen J, Vasen H, Wasielewski M, Wagner A, Hollestelle A, Elstrodt F, van den Bos R, de Snoo A, Fat GTA, Brekelmans C, Jagmohan S, Franken P, Verkuijlen P, van den Ouweland A, Chapman P, Tops C, Moslein G, Burn J, Lynch H, Klijn J, Fodde R & Schutte M (2003), The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype, American Journal of Human Genetics 72(5).
- Cappel WHDTN, Offerhaus GJA, van Puijenbroek M, Caspers E, Gruis NA, de Snoo FA, Lamers CBHW, Griffioen G, Bergman W, Vasen HFA & Morreau H (2003), Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-Leiden), Clinical Cancer Research 9(10).
- Dove-Edwin I., Boks D.E.S., Goff S., Kenter G.G., Carpenter R., Vasen H.F.A. & Thomas H.J.W. (2002), The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma, Cancer 94(6): 1708-1712.
- Hendriks Y, Wagner A, Vasen H, Menko F, Stormorken A, Moller P, Genuardi M, Sandkuijl L, van Houwelingen H, Tops C, Morreau H, de Leeuw W, Meijers-Heijboer H, Breuning M, Fodde R, Wijnen J & Brocker-Vriends A (2002), Phenotype of MSH6 versus MLH1 and MSH2: Lower penetrance and higher age of onset., American Journal of Human Genetics 71(4).
- Boks DES, Trujillo AP, Voogd AC, Morreau H, Kenter GG & Vasen HFA (2002), Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer, International Journal of Cancer 102(2).
- Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, Senie R, Daly MB, West D, Ostrander EA, Offit K, Peretz T, Osorio A, Benitez J, Nathanson KL, Sinilnikova OM, Olah E, Bignon YJ, Ruiz P, Badzioch MD, Vasen HFA, Futreal AP, Phelan CM, Narod SA, Lynch HT, Ponder BAJ, Eeles RA, Meijers-Heijboer H, Stoppa-Lyonnet D, Couch FJ, Eccles DM, Evans DG, Chang-Claude J, Lenoir G, Weber BL, Devilee P, Easton DF, Goldgar DE & Stratton MR (2002), Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium, Proceedings of the National Academy of Sciences 99(2).
- Moller P, Borg A, Evans DG, Haites N, Reis MM, Vasen H, Anderson E, Steel CM, Apold J, Goudie D, Howell A, Lalloo F, Maehle L, Gregory H & Heimdal K (2002), Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy.
- Park JG, Vasen HFA, Park YJ, Park KJ, Peltomaki P, de Leon MP, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lindblom A, Madlensky L & Lynch HT (2002), Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study, International Journal of Colorectal Disease 17(2).
- Wagner A, Tops C, Wijnen JT, Zwinderman K, van der Meer C, Kets M, Niermeijer MF, Klijn JGM, Tibben A, Vasen HFA & Meijers-Heijboer H (2002), Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation, Journal of Medical Genetics 39(11).
- Cappel WHDTN, Nagengast FM, Griffioen G, Menko FH, Taal BG, Kleibeuker JH & Vasen HF (2002), Surveillance for hereditary nonpolyposis colorectal cancer - A long-term study on 114 families, Diseases of the Colon and Rectum 45(12).
- Voskuil DW, Kampman E, Grubben MJAL, Kok F, Nagengast FM, Vasen HFA & van 't Veer P (2002), Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in The Netherlands, European Journal of Cancer 38(17).
- Dove-Edwin I, Boks D, Goff S, Kenter GG, Garpenter R, Vasen HFA & Thomas HJW (2002), The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma, Cancer 94(6).
- Watson P., Bützow R., Lynch HT, Mecklin J.P., Järvinen H.J., Vasen H.F.A., Madlensky L., Fidalgo P. & Bernstein I. (2001), The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer, Gynecologic Oncology 82(2): 223-228.
- Watson P, Butzow R, Lynch HT, Mecklin JP, Jarvinen HJ, Vasen HFA, Madlensky L, Fidalgo P & Bernstein I (2001), The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer, Gynecologic Oncology 82(2).
- Bulow S, Vasen H, Bulow C, Bisgaard ML, Jarvinen H & Bjork J (2001), Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis - Reply, Gastroenterology 121(2).
- Bulow S, Vasen H, Bulow C, Bisgaard ML, Jarvinen H & Bjork J (2001), Ileorectal anastomosis in patients with familial adenomatous polyposis - Reply, Gastroenterology 121(2).
- Vasen HFA, van Duijvendijk P, Buskens E, Bulow C, Bjork J, Jarvinen HJ & Bulow S (2001), Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients, Gut 49(2).
- Vasen HFA, Morreau H & Nortier JWR (2001), Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?, American Journal of Human Genetics 68(6).
- Wagner A, Hendriks Y, Meijers-Heijboer EJ, de Leeuw WJF, Morreau H, Hofstra R, Tops C, Bik E, Brocker-Vriends AHJT, van der Meer C, Lindhout D, Vasen HFA, Breuning MH, Cornelisse CJ, van Krimpen C, Niermeijer MF, Zwinderman AH, Wijnen J & Fodde R (2001), Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree, Journal of Medical Genetics 38(5).
- Vasen HFA, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, Taal BG, Moller P & Wijnen JT (2001), MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families, Journal of Clinical Oncology 19(20).
- de Leeuw WJF, van Puijenbroek M, Merx R, Wijnen JT, Brocker-Vriends AHJT, Tops C, Vasen H, Cornelisse CJ & Morreau H (2001), Bias in detection of instability of the (C)8 mononucleotide repeat of MSH6 in tumours from HNPCC patients, Oncogene 20(43).
- de Leeuw WJF, Dierssen J, Vasen HFA, Wijnen JT, Kenter GG, Meijers-Heijboer H, Brocker-Vriends A, Stormorken A, Moller P, Menko F, Cornelisse CJ & Morreau H (2000), Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients, Journal of Pathology 192(3).
- Vasen HFA (2000), Colorectal cancer and family history, Annales Chirurgiae et Gynaecologiae 89(3).
- van Duijvendijk P, Slors JFM, Taat CW, Oosterveld P, Sprangers MAG, Obertop H & Vasen HFA (2000), Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis.
- Vasen HFA, Gruis NA, Frants RR, van der Velden PA, Hille ETM & Bergman W (2000), Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
- Vasen HFA (2000), Clinical diagnosis and management of hereditary colorectal cancer syndromes, Journal of Clinical Oncology 18(21).
- Peelen T, de Leeuw W, van Lent K, Morreau H, van Eijk R, van Vliet M, Wijnen J, Ligtenberg M, Ginjaar HB, Zweemer R, Menko F, Fodde R, van Ommen GJB, Vasen HFA, Cornelisse CJ & Devilee P (2000), Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis, International Journal of Cancer 88(5).
- Sijmons R, Hofstra R, Hollema H, Mensink R, van der Hout A, Hoekstra H, Kleibeuker J, Molenaar W, Wijnen J, Fodde R, Vasen H & Buys C (2000), Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non-polyposis colorectal cancer, Genes, Chromosomes and Cancer 29(4).
- Peelen T, van Vliet M, Bosch A, Bignell G, Vasen HFA, Klijn JGM, Meijers-Heijboer H, Stratton M, van Ommen GJB, Cornelisse CJ & Devilee P (2000), Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.
- Voskuil DW, Kampman E, Van Geloof W, Grubben M, Kok F, Van Muijen G, Nagengast F, Vasen H & van't Veer P (2000), No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas, Digestive Diseases and Sciences 45(11).
- Bulow C, Vasen H, Jarvinen H, Bjork J, Bisgaard ML & Bulow S (2000), Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis, Gastroenterology 119(6).
- Vasen HFA (2000), When should endoscopic screening in familial adenomatous polyposis be started?
- MIKKELSEN EO, THASTRUP O & CHRISTENSEN SB (1988), EFFECTS OF THAPSIGARGIN IN ISOLATED RAT THORACIC AORTA, Pharmacology and Toxicology -Copenhagen- 62(1): 7-11.